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Genome annotation has a direct impact on the success of genomic studies.
Transcriptome analyses and chromatin immunoprecipitation and sequencing (ChIP-seq)
have been used to functionally annotate genomes. These methods can identify proteincoding genes, non-coding transcripts, and cis-regulatory elements across the genome. The
primary objective of the first study was to functionally annotate the equine genome
through the assessment of nine tissues: adipose, brain, heart, lamina, liver, lung, skeletal,
muscle, testis, and ovary. In the first project, 150 bp, paired-end RNA sequencing (RNAseq) libraries were generated in stallion tissues and compared to previously generated
mare RNA-seq libraries to quantify variation in gene expression due to sex and tissue
type. On average, each tissue expressed (> 10 transcripts per million) over 8,000 genes,
and adipose, liver, and skeletal muscle each had over 900 genes differentially expressed
due to sex (P adj <0.05). In the second study, the peaks of four histone marks, H3K27ac,
H3K4me1, H3K4me3, and H3K27me3, were examined to identify activated regions,
enhancers, promoters, and silencers, respectively. Fifty base pair, paired-end ChIP-seq
libraries were created for each histone mark in stallion tissues and compared to data from
50 bp single-end ChIP-seq libraries from mare tissues. On average, 77,000 activated

regions, 120,000 enhancers, 34,000 promoters, and 32,000 silenced regions were detected
in each stallion tissue. Due to high correlations among sequencing depth, total peaks
called, and tissue-unique peaks, regulatory elements unique to tissue types and sexes
could not be well characterized.
The third study examined genomic variation associated with a congenital defect,
perosomus elumbis, (PE) in Angus cattle. The affected calf was still-born, displaying
lumbar aplasia, and arthrogryposis. Whole-genome sequencing of 31 Angus cattle
identified a frameshift mutation in PTK7 as a candidate variant for the development of PE
in an Angus calf. Despite the implication of PTK7 in similar phenotypes, additional
research is needed to verify the etiology of PE in Angus cattle.
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CHAPTER 1: LITERATURE REVIEW
Equine genomics has vastly improved in the past two decades, yet the annotation
of the equine genome lags behind that of mice and humans. The history of equine
genomics following the development of the first reference genome is reviewed, including
genome annotation, genomic tools, and major genomic studies. Some of the limitations of
current genomic resources are discussed in horses and other livestock species. Many of
these shortcomings in genome annotation have been addressed in the human genome by
the ENCODE Project Consortium. The role of histone modifications in functionally
annotating regulatory elements is discussed in addition to the major accomplishments of
the ENCODE Project. Lastly, the Functional Annotation of Animal Genomes Project
(FAANG), and the state of functional annotation in the equine genome are reviewed to
provide context for the need of RNA-sequencing (RNA-seq) and chromatin
immunoprecipitation and sequencing (ChIP-seq) studies in stallion horses.

Part I. Tools for Equine Genomics
Generation of the Equine Reference Genome
The Human Genome Project aimed to sequence the entirety of the human genome
(Collins & Fink, 1995). This effort took over a decade to complete and resulted in the
first reference genome for the study of human traits and diseases (International Human
Genome Sequencing Consortium, 2001). The finalized reference genome covered about
99% of euchromatic regions and consisted of only 341 gaps but came at a cost of $450
million (International Human Genome Sequencing Consortium, 2004; Spencer, 2001).
Despite the cost, the Human Genome Project had an immense impact on human health,
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biotechnology, and the understanding of genomics as a whole (Hood & Rowen, 2013). In
part due to the technological advances that were cultivated by the Human Genome
Project, the cost of whole genome sequencing has dramatically declined, thus allowing
for the development of reference genomes for other species of interest. One such species
is the horse. The equine industry has had a large economic impact in the U.S. for decades,
growing from a $39 billion industry in 2005 to a $50 billion industry in 2017 (American
Horse Council, 2018). The study of disease and performance traits in these valuable
animals was accelerated by the generation of the first equine reference genome,
EquCab2.0 (Wade et al. 2009).
EquCab2.0 was generated using DNA from a single Thoroughbred mare,
Twilight, and sequenced to 6.8x coverage using bacterial artificial chromosome (BAC)
libraries and Sanger sequencing (Wade et al., 2009). The genomic sequence outlined in
EquCab2.0 consists of 2.5-2.7 gigabases (Gb) with 95% of sequence being assigned to
one of the 32 chromosomes (Wade et al., 2009). The equine genome was predicted to
have 20,322 protein-coding genes with over 81% demonstrating orthology to human
genes (Wade et al., 2009). While EquCab2.0 provided a solid foundation for equine
genomic studies, the limitations of this reference genome have become apparent.
In 2015, the EquCab2.0 reference sequence was compared to the original 28
million Sanger reads used in the assembly and new 40x coverage Illumina short read data
from Twilight (Rebolledo-Mendez et al., 2015). Over 1.9 million variants were identified
between Twilight’s Sanger reads and the reference genome with this number increasing
to nearly 4 million when including the Illumina short read data (Rebolledo-Mendez et al.,
2015). Of these variants, 4% were homozygous in the Sanger reads and 18% were
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homozygous in the Illumina reads (Rebolledo-Mendez et al., 2015). Variants found in the
homozygous state represent loci where neither of Twilight’s alleles match the reference.
This suggests that erroneous base calls could have contributed to the final reference
sequence. Beyond these single nucleotide variants, 42,304 gaps that cover 2.2% of the
genome were identified (Kalbfleisch et al., 2018). Between missing and miscalled bases,
the limitations of EquCab2.0 warranted the generation of an improved reference genome.
Utilizing the foundation of EquCab2.0 and new sequencing approaches, such as
PacBio long read sequencing and Hi-C proximity ligation, the newest equine reference
genome, EquCab3.0, was published in 2018 (Kalbfleisch et al., 2018). Substantial
improvements were observed in contiguity, completeness, and mapability. In this
assembly, all but one chromosome is covered by a single scaffold and gaps were reduced
from 2.2% (EquCab2.0) to 0.34% in EquCab3.0 (Kalbfleisch et al., 2018). Mapabilty also
improved by 2.15% and 0.44%, for RNA sequencing (RNA-seq) and whole genome
sequencing (WGS) datasets, respectively (Burns et al., 2018; Kalbfleisch et al., 2018).
Unlike EquCab2.0, EquCab3.0 also phased haplotypes to select the most common allele
shared amongst four other Thoroughbreds for the reference sequence at loci where
Twilight is heterozygous (Kalbfleisch et al., 2018). Due to the more recent release of
EquCab3.0, many of the genomic tools currently utilized in the equine community were
developed using the EquCab2.0 reference genome.

Development of the Three Equine SNP Arrays
Genetic variation within a species plays an important role in phenotypic variation
amongst individuals. Mutations in the genome can be associated with favorable and/or
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deleterious traits. To explore variation in the equine genome, single nucleotide
polymorphisms (SNPs) were identified in Twilight and representative horses from seven
breeds. Twilight was heterozygous at ~750,000 loci and an additional ~400,000 SNPs
were identified across the seven other breeds (Wade et al., 2009; McCue et al., 2012). On
average, one SNP can be found every 2000 base pairs (bp) in the equine genome (Wade
et al., 2009). These SNPs can be useful for tagging variation across the genome and
identifying polymorphisms associated with traits of interest.
SNP arrays consist of many SNP loci that serve as markers for regions of
variation in the genome. These arrays are dependent on the idea of linkage
disequilibrium, or the concept that loci that are close together on a chromosome are
inherited together at higher frequencies than expected if they were inherited
independently (not linked). With LD present across the genome, the SNPs chosen for a
SNP array are assumed to tag nearby variants that may be associated with traits of
interest. Therefore, genotypes derived from these arrays are often used in genome wide
association studies (GWAS).
An equine SNP array was developed in 2009 to allow for more affordable
genotyping and genome-wide association studies. The EquineSNP50 BeadChip was
developed using SNPs documented in the EquCab2.0 reference genome. This SNP chip
contained ~53,500 SNPs that were validated by at least one heterozygous call amongst
351 horses that were successfully genotyped on the array (McCue et al., 2012). The SNPs
fall approximately every 43 kilobases (kb) across the 31 autosomes and every 49 kb
across the X chromosome (McCue et al., 2012). Assessing 14 breeds, McCue (2012)
determined 49,603 (91.1%) of the SNPs on the array to be informative, or having a minor
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allele frequency (MAF) greater than 0.05; however, the number of informative SNPs
dropped substantially when analyzing some breeds alone (McCue et al., 2012). For
example, only 37,053 or 68% of SNPs were informative in the Norwegian Fjord (McCue
et al., 2012).
Shortly after the development of the EquineSNP50 BeadChip, the EquineSNP70
BeadChip was released consisting of approximately 46,000 informative SNPs from the
50K array and ~19,000 new SNPs (Chassier et al., 2018; Schaefer & McCue, 2020). The
70K array has one SNP approximately every 35kb and provides markers in gaps
previously identified in the 50K array (Schaefer & McCue, 2020). Despite the
improvements made in the EquineSNP70 BeadChip, the SNP density was only moderate,
and areas of uneven genomic coverage remained (Schaefer et al., 2017). Furthermore, LD
was found to decay rapidly and reached r2 < 0.2 within 50kb when considering 14 horse
breeds (McCue et al., 2012). Based on variation in haplotypes and LD across breeds,
Wade et al. (2009) suggested that at least 100,000 SNPs would be required for effective
GWAS.
The third and newest commercially available SNP array was made available in
2017 and contains 670,805 SNPs identified in the whole genome sequence of 153 horses
across 24 breeds (Schaefer et al., 2017). These SNPs on the MNEc670K array were
derived from a larger discovery array including over 2 million SNPs. The MNEc670K
array was designed to include SNPs that tagged common haplotypes across the genome
in 15 breeds (Schaefer et al., 2017). The number of SNPs required to recreate all-breed
specific haplotypes varied by breed, with ponies, draft horses, and Quarter horses,
requiring over 350,000 tagging SNPs and Thoroughbreds and Icelandic horses requiring
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less than 150,000 tagging SNPs (Schaefer et al., 2017). The final MNEc670K array
includes ~220,000 SNPs tagging haplotypes in four or more breeds, ~70,000 found on
earlier SNP arrays, and ~7,000 SNPs in the highly studied major histocompatibility
complex (MHC) region (Schaefer et al., 2017). The 670K array has at least 8 SNPs across
every 50 kb region in the genome with approximately 3.7 kb between each SNP
(Schaefer et al., 2017). Genome coverage was vastly improved by the 670K SNP array.

Genome Wide Association Studies in the Horse
All three equine SNP arrays have been applied to a wide variety of studies. Some
applications include studies of fertility (Raudsepp et al., 2012; Gottschalk et al., 2016),
racing performance (Binns et al., 2010), conformation (Singer-Hasler et al., 2012;
Frischknecht et al., 2015), domestication (Schubert et al., 2014), and breed variation
(McCue et al., 2012; Petersen et al., 2013). SNP arrays have also been employed to
identify quantitative trait loci (QTL) associated with complex disease, such as
osteochondrosis (OC) (Schaefer & McCue, 2020).
OC is characterized by the failure of ossification in the cartilage of growing bones
and can impair the performance of young horses making it a disease of particular interest
(McCoy et al., 2016). A variety of studies have associated genetic risk loci on multiple
chromosomes with OC in Hanoverian warmbloods, Standardbreds, and Thoroughbreds
(Dierks et al., 2007; Lampe et al., 2009; Lykkjen et al., 2010; Corbin et al., 2012; McCoy
et al., 2016). Yet, little consensus among risk loci exists across studies. Although
environment certainly contributes to OC, the high prevalence of the disease in certain
breeds, like the Standardbred, suggests that genetic association efforts are not futile
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(McCoy et al., 2016). Improvement of sequencing technologies and genome annotation
may allow for the identification of functional candidate mutations among the QTLs
identified by GWAS in the future.
In addition to complex traits, the equine SNP arrays have been useful in
identifying loci associated with congenital defects. A study by Drögemüller (2014) into
congenital hepatic fibrosis (CHF) of Franches-Montagnes identified a single SNP tagging
a 952kb haplotype in affected horses that contained the polycystic kidney and hepatic
disease 1 gene (PKHD1). PKHD1 has been previously implicated in similar phenotypes
in humans (Drögemüller et al., 2014). Despite the inability to identify a perfectly
associated causative variant with subsequent whole genome sequencing, further research
into the PKHD1 gene relative to hepatic fibrosis may be warranted (Drögemüller et al.,
2014). Another condition that appears shortly after birth in affected horses is equine
guttural pouch tympany (GPT). This disease is characterized by abnormal distention of
air-filled tubes in the head of horses that results in labored breathing, difficulty
swallowing, and pneumonia (Metzger et al., 2012). In studies of Arabians and German
Warmbloods risk loci were identified on two different chromosomes, but putative causal
mutations were not found (Metzger et al., 2012). These studies exemplify common
outcomes of GWAS where genomic regions can be successfully associated with a trait
but the function of the genome in that region to result in the studied outcome is not clear.
In some cases, additional sequencing of associated genes has led to putative causal
mutations within protein coding genes.
SNP arrays have proven successful in identifying strong functional candidates in
some congenital defects when combined with Sanger sequencing and WGS. Lavender
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Foal Syndrome (LFS) is a neurologic disorder accompanied by a coat color dilution
present in Egyptian Arabian horses (Brooks et al., 2010). GWAS with SNP genotyping
and subsequent Sanger sequencing, identified a single base pair deletion in the MYO5A
associated with LFS (Brooks et al., 2010). MYO5A was linked to similar disorders in
mice and humans, and the single base pair deletion in horses disrupted a highly conserved
region of the gene (Brooks et al., 2010). The use of Sanger sequencing to examine
GWAS hits provided a strong functional candidate for LFS (Brooks et al., 2010). Similar
methods were used to identify a putative mutation for Naked Foal Syndrome (NFS) in
Akhal-Teke horses (Bauer et al., 2017). Bauer (2017) used 670K SNP data to associate
haplotypes with NFS. Subsequent whole genome sequencing of two cases and two
controls identified a nonsense mutation in ST14 associated with NFS (Bauer et al., 2017).
ST14 had previously been implicated in hair follicle development in mice making the
nonsense mutation in ST14 a strong functional candidate for the hairless phenotype of
NFS foals (List et al., 2003; Bauer et al., 2017). Although some traits of interest have
been successfully associated with strong functional candidates, putative causative
variants have not been identified for many other important traits.

Limitations of Reference Genomes and SNP Arrays
Reference genomes and SNP arrays provide a strong foundation for genetic
studies; however, there are limits to the usefulness of these resources. Differences
between the population being studied and the reference sequence as well as shortcomings
in the annotation of the reference can inhibit the productivity of genetic studies.
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Structural variants in the genome often exist between breeds of the same species. One
such example was demonstrated in cattle.
The most current Bos taurus reference genome, ARS-UCD1.2, is based on a
Hereford cow that is highly inbred (Rosen et al., 2020). This high-quality reference
genome contains a single scaffold for each of the 30 bovine chromosomes and only 459
gaps across the 2.6 Gb sequence (Rosen et al., 2020). Despite the 200-fold increase in
continuity and 10-fold increase in accuracy compared to the previous reference from the
same Hereford cow, UMD3.1.1 (Zimin et al., 2009), the ARS-UCD1.2 reference still has
difficulties capturing variants of interest in distantly related cattle breeds (Rosen et al.,
2020).
Development of reference genomes for other breeds of interest has been
underway and demonstrates the genomic differences between breeds. The development
of two haplotype-resolved reference genomes for Angus and Brahman cattle through trio
binning identified genetic differences between Angus, Brahman, and Hereford cattle. The
number of structural variants identified among six Brahman and five Angus cattle was
dependent on whether the cattle were mapped to their corresponding breed’s reference
sequence (Low et al., 2020). As expected, a greater number of structural variants, such as
deletions, duplications, and inversions, were observed when mapping cattle to the
opposite breed’s reference sequence (Low et al., 2020). When comparing the Brahman
(UOA_Brahman_1) and Angus (UOA_Angus_1) reference genomes to the Hereford
ARS-UCD1.2 reference genome, 0.4% of UOA_Angus_1 and 0.8% of UOA_Brahman_1
consisted of structural variants (indels, expansions, and contractions) compared to ARSUCD1.2 (Low et al., 2020). The work by Low et al. (2020) demonstrate that genetic
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variation does exist between cattle breeds and that reference genome selection impacts
the ability to accurately identify variation across breeds.
Another study examining the impact of reference genome selection on WGS
studies of Brown Swiss cattle identified differences in annotation between ARS-UCD1.2
and UOA_Angus_1. Few differences in mapping accuracy and SNP calling were
identified when mapping WGS from Brown Swiss cattle to ARS-UCD1.2 and
UOA_Angus_1; however, the annotation of variants using Ensembl’s Variant Effect
Predictor (VEP) showed significant differences between the two reference assemblies
(Lloret-Villas et al., 2021). Nearly 10% more SNPs and indels were annotated as
intergenic in ARS_UCD1.2 than UOA_Angus_1 (Lloret-Villas et al., 2021). SNPs and
indels were found in intronic regions 10% more often in UOA_Angus_1 than
ARS_UCD1.2 (Lloret-Villas et al., 2021). Minor differences were observed between the
two reference genomes when considering variants in exons (Lloret-Villas et al., 2021).
Signatures of selection occur when selection pressure results in the loss of variation at
loci near causative variants and can be identified by alleles close to fixation or alleles
recently fixed within a population (Lloret-Villas et al., 2021). When considering
signatures of selection, 40 regions of selection were identified in ARS_UCD1.2
compared to 33 regions in UOA_Angus_1, but little overlap between loci was observed
between the two references (Lloret-Villas et al., 2021). This demonstrates that reference
genome can significantly impact the outcome of some genetic studies. Furthermore, the
study by Lloret-Villas et al. (2021) suggests that a portion of chromosome 13 is inverted
in the UOA_Angus_1 reference. These differences in annotation can be especially
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inhibitory to studies where candidate variants are filtered by their predicted impact on
gene function.
Genome wide association studies can also be limited by the annotation of
reference genomes. Most reference genomes are annotated using a variety of methods,
including comparing sequences from other species, utilizing transcriptome data, and ab
initio gene prediction based on the sequence itself. Gene structures are frequently
predicted by two main genome databases, National Center for Biotechnology Information
(NCBI) and Ensembl. The predicted protein-coding gene lists for the EquCab2.0 equine
reference genome consisted of 20,322 genes from Ensembl and 17,610 genes from NCBI
(Coleman et al., 2010). To identify 5’ and 3’ ends as well as exons, introns, and splice
junctions, Coleman et al. (2010) generated RNAseq data from 8 tissues to clarify the
structure of protein-coding genes predicted by Ensembl and NCBI. After generating
almost 300 million sequence tags, Coleman (2010) refined the structure of 11,356 genes.
When considering loci that did not represent overlapping genes or pseudogenes, 89% of
genes predicted by Ensembl and NCBI displayed expression in at least one of the eight
studied tissues (Coleman et al., 2010). Ultimately, a consensus gene set consisting of
20,302 protein coding genes was defined; however, these protein coding genes only
comprise about 1.28% of the genome (Coleman et al., 2010). A later study examining
RNAseq data from 43 tissues in the horse identified 68,594 transcripts in which 71% of
the transcripts overlapped previously annotated genes (Hestand et al., 2015). Of the
20,039 transcripts that did not align to previously annotated loci, over 90% contained a
single exon, suggesting that some of these transcripts may correspond to non-coding
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RNAs (ncRNAs), unannotated small open reading frames (smORFs), or gene fragments
that were improperly constructed in the equine reference genome (Hestand et al., 2015).
In the past, annotation of genomes primarily focused on protein coding genes;
however, of the ~20,000 protein coding genes found in most mammalian species, the
protein coding sequence comprise less than 2% of the genome (Coleman et al., 2010; The
ENCODE Project Consortium, 2012). This is particularly inhibitory to GWAS as one
study found 88% of human trait associated loci fell within intronic and intergenic regions
(Hindorff et al., 2009). Many other functional elements exist within the genome outside
of protein-coding genes, including ncRNAs, transcription factor binding sites,
transcriptional regulatory elements, and DNA methylation sites (The ENCODE Project
Consortium, 2012). The large-scale annotation of these functional elements was
undertaken by the Encyclopedia of DNA Elements (ENCODE) Project, and the
discoveries made in this project have drastically changed our understanding of genome
function.

Part II. Progress Toward Functional Annotation
The ENCODE Project: Overview and Pilot Phase
The human ENCODE Project began in 2003 with the intent of annotating all
functional elements in the human genome and was subdivided into three phases: pilot,
technology development, and production (The ENCODE Project Consortium, 2004). In
the pilot phase, the consortium aimed to identify procedures that could accurately and
economically characterize large portions of the human genome (The ENCODE Project
Consortium, 2004). Concurrently, the technology development phase aimed to develop
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laboratory and computational procedures to address the gaps in technology discovered in
the pilot phase (The ENCODE Project Consortium, 2004). Between these two phases, the
most efficient technologies and protocols for functional annotation would be determined
to allow for a comprehensive and economical assessment of the entire human genome in
the production phase (The ENCODE Project Consortium, 2004).
The pilot phase of ENCODE assessed suitable methods for large scale functional
annotation by focusing on a 30 Mb region of the genome (~1%) split into forty-four 0.5-2
Mb regions (The ENCODE Project Consortium, 2004). The ENCODE Project
Consortium (2004) manually chose approximately half of these regions to represent
stretches of genome containing well characterized genes or regulatory elements with
large amounts of comparative sequence data to leverage preexisting knowledge. The
remaining target regions were selected with an algorithm that ensured selection of
representative regions in terms of gene content and non-exonic conservation between
humans and mice (The ENCODE Project Consortium, 2004). The consortium examined a
variety of technologies in the pilot phase including transcript microarray assays,
chromatin immunoprecipitation microarray hybridization (ChIP-chip), computational
gene calling methods, and expression reporter assays. These technologies were employed
with the intent of identifying genes and their cis-regulatory elements (promoters,
enhancers, repressors, and silencers), transcription start and end sites, transcription factor
binding sites, DNA methylation sites, accessible chromatin, chromatin modifications, and
conserved regions across species (The ENCODE Project Consortium, 2004).
A synthesis of the results from the pilot phase were published by the ENCODE
Consortium in 2007, including transcriptome analyses, novel transcription start site
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annotation, regulatory element identification, DNA replication regulation, and
evolutionary constraint analysis across mammalian species (The ENCODE Project
Consortium, 2007). Only 2% of transcripts identified were found in all sample types,
whereas 40% of transcripts were found in only one sample type (The ENCODE Project
Consortium, 2007). Rapid amplification of cDNA ends (RACE) was used to clarify the 5’
ends of transcripts. RACE products were hybridized with tiling arrays and added to
complement the previous datasets. Over 70% of the bases in the ENCODE region were
contained within unspliced, primary transcripts that were identified in multiple assays
(The ENCODE Project Consortium, 2007). When assessing transcription start sites
(TSSs), ~2,700 novel TSSs were identified and supported by a similar presence of
transcription factors, histone modifications, and DNase I accessibility at known and novel
TSSs (The ENCODE Project Consortium, 2007). These chromatin structural
modifications were also found to be able to predict the location and activity of TSSs with
up to 91% accuracy (The ENCODE Project Consortium, 2007). The presence of histone
modifications was also correlated with the signal of DNA replication. Activating histone
modifications such as histone 3 acetylation and histone 3 lyisne 4 mono- and trimethylation were negatively correlated with replication signals, while repressive
modifications, such as histone 3 lysine 27 trimethylation, were positively correlated with
replication signals (The ENCODE Project Consortium, 2007). The presence of activating
histone marks fell within open chromatin between 81-93% of the time as noted by DNase
I hypersensitive sites (DHSs); however, 29-57% of DHSs lacked activating histone
modifications (The ENCODE Project Consortium, 2007). To assess if these regulatory
elements were in conserved regions of the genome, regions of evolutionary constraint
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were examined. Evolutionary constraint is defined as regions of the genome that reject
mutations and that can be identified by assessing the frequency of intraspecies
polymorphisms (The ENCODE Project Consortium, 2007). Approximately 50% of noncoding functional elements are found in unconstrained regions across mammals,
suggesting variation in these elements both within and between species (The ENCODE
Project Consortium, 2007).
Overall, the pilot phase of ENCODE, studying just 1% of the human genome,
provided a wealth of new knowledge regarding genome function. As much as 74% of the
genome is transcribed and transcription is tissue-specific in many cases. The presence of
transcription factors and histone modifications were symmetrical around TSSs,
suggesting the functional relevance of regulatory elements both upstream and
downstream of the TSS (The ENCODE Project Consortium, 2007). Further evidence was
provided to suggest that histone modifications can be used to identify regulatory elements
and transcriptional activity. Lastly, almost half of functional non-coding elements were
located within non-conservative regions of the genome, warranting further study of these
regulatory elements both across tissue types and in other species. The findings of the pilot
phase foreshadowed the impact of the overall ENCODE project which has resulted in
over 7,400 published studies to date.

Transcriptome Analyses in the ENCODE Project
Transcription results in RNA products that collectively makeup the transcriptome.
The transcriptome can be defined by just the messenger RNAs (mRNAs) produced from
the transcription of protein coding genes or as all RNAs within the cell, including non-
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coding RNAs. As RNA is transcribed by RNA polymerase II, a modified guanine cap is
added to the 5’ end of the RNA which functions to prevent its degradation. Messenger
RNA is also polyadenylated at the 3’ end, and both the 5’ cap and 3’ poly-A tail are
involved in translation (Gertsel et al., 1992). Long non-coding RNAs (lncRNAs) can also
be modified to include 5’ caps and 3’ poly-A tails (Guttman et al., 2009). Not all
lncRNAs, however, are polyadenylated (Cheng et al., 2005; Yang et al., 2011). Various
technologies leverage these post-transcriptional modifications for transcriptome analyses.
For example, cap analysis gene expression (CAGE) captures transcripts by targeting the
5’ cap and poly-A tail selection is often used to focus sequencing effort on mRNA
transcripts (Carninci et al.,1996; Zhao et al., 2018).
The early phases of the ENCODE project used a variety of technologies to
characterize the transcriptome, including CAGE, RNA paired end tagging (PET), and
tiling arrays (The ENCODE Project Consortium, 2007). The methods used in the later
phases of the ENCODE project employed newer technologies, such as massively parallel
sequencing, capable of generating larger amounts of data. A newer approach to
transcriptome analysis is RNA-seq which employs next-generation sequencing (NGS).
RNA-seq allows for an in depth look at gene structure as transcripts are fragmented and
fitted with adapters on one or both ends of the fragment. Between 30 and 400 base pairs
are sequenced from each adapter creating reads that map across the length of the
transcript (Wang et al., 2009). RNA-seq provides an advantage over earlier technologies
as it can help identify intron/exon boundaries and different isoforms associated with a
gene (Wang et al., 2009).
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A large degree of the understanding of transcription across the genome is derived
from the results of the ENCODE project. In the production phase where the entirety of
the human genome was assessed, Djebali (2012) explored transcription in 15 cell lines
using a variety of methods. Within the 15 cell lines, 62 and 74% of the genome was
contained within processed and primary transcripts, respectively (Djebali et al., 2012).
The processed transcripts from a single cell line covered 22% of the genome on average
and no single cell line possessed more than 57% of the transcripts identified across all 15
cell lines (Djebali et al., 2012). Djebali (2012) determined approximately 50% of proteincoding transcripts to be ubiquitously expressed in all 15 cell lines, while only 7% were
cell line specific. Djebali (2012) found the opposite to be true for lncRNAs of which
nearly 30% of transcripts were cell line specific and only 10% were found in all studied
cell lines. Many genes can produce multiple isoforms, yet a single isoform generally
comprises the majority of transcripts in a given condition (Djebali et al., 2012). Some
distal enhancer sequences were found to be transcribed, but both the degree of
transcription and chromatin modifications associated with the enhancer regions were
found to be cell line specific (Djebali et al., 2012). Djebali’s 2012 findings increased the
GENCODE annotation of the human genome to include 45% more transcripts and 80%
more genes, many of which were mono-exonic. Overall, this work emphasized the
importance of assessing the transcriptome across a variety of cell types and demonstrated
that the majority of the genome is contained within primary transcripts. The findings
from the ENCODE project have been integrated into an annotation called GENCODE.
The GENCODE annotation is a gene set comprised of genes manually annotated
by the Human and Vertebrate Analysis and Annotation (HAVANA) group and genes
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automatically annotated by Ensembl (Harrow et al., 2012). The GENCODE 7 release,
published alongside the ENCODE paper, summarizing the results from the production
phase, included 20,687 protein-coding genes, 9,640 lncRNAs, and approximately 10,000
pseudogenes (Harrow et al., 2012). Over 140,000 alternative transcripts were proposed in
the GENCODE gene set compared to the RefSeq and UCSC annotations, yet many of
these alternative transcripts were missing either their 5’ or 3’ ends (Harrow et al., 2012).
When assessing the predicted exon-exon junctions in transcripts and the presence of
novel transcripts, RT-PCR and sequencing validated 82% of the identified exon-exon
junctions and 73% of novel transcripts (Harrow et al., 2012). The GENCODE 7 release
provided a solid foundation for genomic studies in humans, yet the GENCODE
annotation has been consistently updated since its original release. As of 2021, the
GENCODE gene set consists of 19,954 protein coding genes, 17,957 lncRNAs, 14,767
pseudogenes, 7,569 small RNAs, 645 immunoglobin/T cell receptor genes, and over
230,000 transcripts (Frankish et al., 2021). Overall, the ENCODE project significantly
impacted genomics studies by emphasizing the variation in gene expression present
across cells and tissues and the pervasive presence of non-coding genes in the genome.
The findings from this project have inspired transcriptomic studies in other species,
including the horse.

Transcriptome Studies in the Horse
In the horse, most transcriptome studies have been limited in the tissues assayed
either determining differential expression associated with traits of interest or improving
the annotation of the reference genome. Studies aimed at determining the impact of
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exercise on gene expression have assessed the transcriptome of blood and skeletal muscle
in Thoroughbred and Arabian horses (McGivney et al., 2010; Park et al., 2012;
Capomaccio et al., 2013; Ropka-Molik et al., 2017). Some studies focused on differential
gene expression between untrained and trained muscles (McGivney et al., 2010; RopkaMolik, 2017), while others assessed changes in gene expression immediately following
exercise ranging from 30 min of trotting (Park et al., 2012) to endurance races of nearly
100 miles (Capomaccio et al., 2013). Genes involved in the immune system, the cell
cycle, signal transduction, and lipid metabolism were found to be differential expressed
immediately following exercise (Park et al., 2012; Capomaccio et al., 2013). Genes
displaying differential expression following long term training include those involved in
metabolism, muscle growth and development, and mitochondrial function (McGivney et
al., 2010; Ropka-Molik et al., 2017). Some of these studies also recognized transcripts in
unannotated regions of the genome suggesting both the presence of noncoding genes and
the limitations of the EquCab2.0 reference annotation at the time they were published
(Park et al., 2012; Capomaccio et al., 2013).
Further studies have examined the transcriptome relative to reproduction. Sperm
were previously believed to have minimal transcriptomes reflecting that of the testis;
however, Das and others (2013) identified 202 transcripts in sperm that were not
expressed in the testis. Further examination of the sperm transcriptome using RNA-seq,
identified over 19,000 transcripts present in the sperm compared to ~6,600 identified
using a microarray (Das et al., 2013). Many of the transcripts consisted of micro RNAs
(miRNAs), genes on the Y chromosome, and those involved in sperm specific functions
(Das et al., 2013). Although ~13,000 transcripts did not align to annotated elements in
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EquCab2.0, Das (2013) demonstrated the complexity of the sperm transcriptome. Iqbal
and colleagues (2014) characterized the transcriptomes of equine embryonic cells and
assessed differential expression between the inner cell mass (ICM) and trophectoderm
(TE). Over 10,000 genes were expressed in both ICMs and TE with 1201 transcripts
exclusive to ICM and 705 transcripts unique to TE (Iqbal et al., 2014). Genes
overexpressed in ICM were related to cell differentiation, cell migration, and
regeneration while genes overexpressed in TE corresponded to placental development
and cellular transport (Iqbal et al., 2014). Together, these studies demonstrate some of the
benefits of RNA-seq technology, including greater detection of transcripts and the ability
to generate high-quality RNA libraries from cells within a single embryo; however, the
lack of progression in genome annotation prevented the characterization of over twothirds of the transcripts expressed in sperm (Das et al., 2013).
Gene expression in the equine immune system has been assessed in various
lymphoid tissues and leukocytes. One study assessed the transcriptome related to six
immune related cells and tissues, including lymphocytes, spleen, lymph node, liver,
jejunum, and kidney. The consensus transcriptome from these cells and tissues showed
little overlap with Ensembl’s annotation of gene structure, and over 8,000 novel isoforms
were identified (Moreton et al., 2014). Furthermore, 91 families of paralogs were
expanded in the horse compared to the human, with 83 of 91 determined to be simple
duplications (Moreton et al., 2014). Peripheral blood mononuclear cells (PBMCs) are
another form of immune cell that modulate both the innate and adaptive immune system.
Examining the transcriptome of 561 PBMC cultures from 85 Warmblood horses, 42,602
predicted genes were expressed (Pacholewska et al., 2015). Over 7,500 unannotated

21
transcripts were identified with 57% demonstrating homology to expressed sequence tags
found in other species (Pacholewska et al., 2015). This study identified 543 novel
transcripts with high coding potential with 61 of these novel coding genes unique to the
horse (Pacholewska et al., 2015). Both studies provided information regarding gene
expression in immune cells and tissues and once again identified opportunities to improve
the annotation of EquCab2.0.
Many other equine transcriptome studies have taken place. One study assessed the
differential gene expression between the Korean Jeju horse and Thoroughbred horses.
Five tissues were selected for the comparison including skeletal muscles of the rump and
thigh, liver, heart, and lung (Srikanth et al., 2019). Over 5,400 genes were differentially
expressed between Jeju and Thoroughbred tissues with genes involved in process such as
angiogenesis and cell adhesion, muscle cell differentiation, fat metabolism, and
molecular signaling pathways (Srikanth et al., 2019). Of the differentially expressed
genes, 71 were in regions identified as signatures of selection between the two breeds
including genes related to body size, muscle fiber type, and mitochondrial function
(Srikanth et al., 2019). Another unique study examined the difference in gene expression
between fetal, adult, and embryonic stem cell derived tenocytes. This study identified 542
differentially expressed genes between the fetal and adult tenocytes when cultured in 3D;
however, only 10 genes were differentially expressed when the tenocytes were cultured
in a 2D monolayer (Paterson et al., 2020). This is interesting as it suggests that different
methods of cell culture can greatly impact gene expression and that the transcriptome of
cultured cells may not reflect genes expressed in vivo. These studies exemplify the range
of applications of transcriptome analysis.
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In 2017, equine transcriptome data available from a variety of sources was
compared to a new transcriptome derived from 59 samples across 8 tissues (Mansour et
al., 2017). The transcriptome built by Mansour et al. (2017) matched most closely with
that derived from PBMCs by Pacholewska et al. (2015) followed by the annotation
available from NCBI. About 50% of the 76,125 transcripts identified by Mansour et al.
(2017) were shared across the transcriptomes generated by Pacholewska et al. (2015),
Hestand et al. (2015), NCBI, and Ensembl (Mansour et al., 2017). The study by Mansour
et al. (2017) also assessed differences in gene expression across tissues; however, there is
likely technical bias present in this comparison as different methods were used to
generate libraries across tissues, including single-end vs paired end reads, rRNA
depletion vs polyA+ selection, and stranded vs unstranded libraries (Mansour et al.,
2017). Work utilizing the transcriptome from Mansour et al. (2017) assessed lncRNAs in
the equine genome (Scott et al., 2017). Nearly 21,000 lncRNAs were identified across 8
tissue types; however, more lncRNAs likely exist due to the fact that lncRNAs are
frequently expressed in a tissue-specific manner (Djebali et al., 2012; Scott et al., 2017).
Altogether, these studies provided expansion and validation of the annotation of the
equine genome.
Together, these studies of the equine transcriptome have bolstered the annotation
of the equine genome and provided a foundation for the study of differential gene
expression across tissues, breeds, and phenotypes. Despite the advancements made via
these studies, limitations in experimental design and methodology have prevented an
unbiased comparison of gene expression across a wide variety of tissues. Many studies
have examined only a single tissue or cell type, while others have combined numerous
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tissue samples to create a single transcriptome. In studies where gene expression across
tissues was compared, differences in library preparation and read depth have confounded
biological differences between tissues (Mansour et al., 2017). Additional research that
prioritizes the reduction of technical bias will be necessary to better understand tissuespecific gene expression. Although transcriptomic studies can identify differences in gene
expression, not all cis-regulatory elements modulating these changes can be identified
through RNA-seq. Other methods, such as chromatin immunoprecipitation and
sequencing (ChIP-seq), can be utilized to identify histone modifications associated with
cis-regulatory elements such as enhancers, promoters, and polycomb repressors.

Overview of Histone Modifications
DNA within the cell is condensed and stored as chromatin. The basic unit of
chromatin is the nucleosome which consists of 147 bp of DNA coiled around histone
proteins. Nucleosomes are connected by short stretches of DNA, termed linker DNA,
which creates the primary chromatin structure resembling beads on a string (Figure 1.1).
Each nucleosome organizes about 200bp of DNA when accounting for both the wrapped
and linker DNA (McGinty & Tan, 2015). Folding and coiling of the primary chromatin
creates secondary and tertiary chromatin structures that are highly compact. Most
transcriptionally active regions of the genome are believed to fall in loosely packaged
DNA, termed euchromatin, while transcriptionally repressed regions of the genome are
believed to exist mostly in the condensed heterochromatin (Morrison & Thakur, 2021).
Beyond chromatin unpacking, nucleosomes are often temporarily removed in regions of
active gene expression (Lee et al., 2004). Although gene expression is more common in
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areas of loosely packed DNA, some studies suggest that transcription can still occur in
regions of tertiary chromatin
(Zhou et al., 2007; Hu et al.,
2009). Both the location of
nucleosomes and the compaction
of chromatin are dynamic
allowing for changes in
transcriptional programs. The
location and degree of chromatin
compaction can be altered by the
binding of various proteins
including chromatin remodeling
ATPases, transcription factors,
and histone modifying enzymes
(Mellor, 2005). Here, we will
focus on the impact of various
histone modifications on
Figure 1.1. DNA Packaging and Chromatin
Structure
The primary structure of chromatin is the most
accessible (euchromatin) and resembles beads on a
string. The secondary structure is defined as the 30-nm
fiber. The tertiary structure refers to the looping and
coiling of the chromatin fiber. The secondary and
tertiary structures are referred to as heterochromatin.
Figure created with BioRender.com

transcription.
Each nucleosome contains
a histone protein of eight subunits
with two copies each of H2A,

H2B, H3, and H4 (Arents et al., 1991). Each histone subunit has a N-terminal tail that
protrudes from the nucleosome core consisting of 25-59 amino acids (Grant, 2001; Nurse
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et al., 2013) (Figure 1.2). The N-terminal tails of the H4 and H2A subunits fall outside
the nucleosome while the N-terminal
tails of the H2B and H3 subunits fall
between the DNA gyres on the
nucleosome (McGinty & Tan, 2015).
The N-terminal tails of histones play a
key role in chromatin compaction.
Histone tails can interact with DNA and

Figure 1.2. Nucleosome Structure
A drawing depicting the octamer structure of a
nucleosome. Each subunit has N-terminal tail
extending from the nucleosome. Figure
created with BioRender.com

other histone cores to pull nucleosomes together (Arya et al., 2009; Nurse et al., 2013).
The positive charge on the histone tails helps overcome the repulsive forces generated
between the negatively charged DNA allowing for tighter packing of nucleosomes (Arya
et al., 2009). Studies have found that the removal of histone tails impairs oligomerization
of nucleosomes and demonstrated that the N-terminal tails of all histone subunits are
involved to some degree in the assembly of chromatin structures (Tse & Hansen, 1997;
Gordon et al., 2005; Nurse et al., 2013). Therefore, it is not surprising that chemical
modifications to the N-terminal tails impact both chromatin structure and transcription.
Many post-translational modifications to lysine and arginine residues along the Nterminal tails have been identified. The impact of acetylation and methylation along
histone tails was first explored by Allfrey et al. (1964). Deposition of acetyl and methyl
groups along histone tails can impact transcription through alteration of the electrostatic
environment of the nucleosome and the recruitment of various transcription factors
(Bannister & Kouzarides, 2011). The biological role of four commonly studied histone
modifications and the techniques used to study their locations will be discussed.
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The common nomenclature for post translational histone modification includes
naming modifications with the histone subunit (e.g.H3), the residue (e.g. lysine 27 or
K27), and the chemical modifier (e.g. ac for acetylation or me3 for trimethylation).
Although many modifications have been identified across all 4 types of histone subunits,
the focus of this review will include 4 commonly studied H3 modifications (H3K27ac,
H3K4me1, H3K4me3, and H3K27me3). The N-terminal tail of H3 is the longest of all
the subunits, consisting of 59 amino acids, and is of particular interest as the histone tail
interacts directly with nucleosomal DNA (Nurse et al., 2013).

Histone Acetylation: H3K27ac
Acetylation of various components of histone proteins and its impact on genomic
function have been studied since the 1960s. Acetylation of histone proteins is regulated
by histone acetyltransferases (HATs) and histone deacetylases (HDACs). HATs place
acetyl groups on histone proteins and can be separated into two categories, Type A HATs
and Type B HATs. Type B HATs are involved in acetylating histone subunits in the
cytosol, while Type A HATs are found in the nucleus and acetylate histones already in
nucleosomes (Gujral et al., 2020). HATs use acetyl CoA as a cofactor to transfer acetyl
groups to the lysine residues of the histone tails (Bannister & Kouzarides, 2011).
Common Type A HATs include p300, CBP, and GCN5 (Bordoli et al., 2001; XueFranzén et al., 2013; Gujral et al., 2020). HDACs function to remove acetyl groups from
both histone proteins and nonhistone proteins (Seto & Yoshida, 2014). The presence of
HDACs were first identified in 1969 by Inoue & Fujimoto, but the first HDAC was not
isolated and cloned until 1996 (Inoue & Fujimoto, 1969; Taunton et al., 1996). Since
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their discovery, 18 HDACs have been identified in humans (Seto & Yoshida, 2014).
HDACs use either zinc or NAD(+) to remove acetyl groups from proteins (Finnin et al.,
1999; Imai et al., 200; Seto & Yoshida, 2014). Together, HATs and HDACs regulate
chromatin structure and transcription.
Acetylation of both the histone core and histone tails can impact nucleosome
structure and chromatin folding. Acetylation of the histone cores and tails reduces the
number of turns of DNA (Bauer et al., 1994) and induces a reduction in the degree of
chromatin folding independent of H1 linker binding protein, which functions to stabilize
the nucleosome (Garcia-Ramirez et al., 1995; Wang et al., 2001). The reduction in
chromatin folding resulting from acetylation of the histone tails is proposed to be due to a
partial neutralization of the positive charge on the histone tail that impairs the interaction
of the tail with the linker DNA between nucleosomes (Garcia-Ramirez et al., 1995;
Bannister & Kouzarides, 2011). Although the chemical effect of acetylation of individual
residues in histone tails has not been thoroughly explored, the impact of H3K27ac on
transcription and gene function has been examined closely.
Histone acetylation was implicated in increasing transcriptional activity as early
as 1964 (Allfrey et la., 1964). Many studies broadly examined H3 acetylation in relation
to gene expression and regulation. The initial phase of the ENCODE project identified
enrichment of H3 acetylation at the TSS of genes and demonstrated greater enrichment at
genes that were active and near CpG islands (The ENCODE Project Consortium, 2007).
H3K27ac, among other H3ac, was also demonstrated to localize at TSSs (Wang et al.,
2008). Enhancers are another cis-regulatory element that play a key role in increasing
gene expression. The presence of H3K27ac has been shown to differentiate active
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enhancers from poised enhancers (Creyghton et al., 2010). Furthermore, H3K27ac is
often identified at enhancer clusters, termed super-enhancers (Hnisz et al., 2013). A
recent study demonstrated that p300/CBP mediated acetylation is directly responsible for
activating enhancers and initiating transcription at enhancer-regulated genes (Narita et al.,
2021). The study determined that acetyltransferase activity was required for transcription
factor and RNA polymerase II recruitment to enhancer-regulated genes (Narita et al.,
2021). CBP has been shown to be essential for H3K27ac, while knock down of GCN5
showed little effect on H3K27ac (Tie et al., 2009). This suggests that H3K27ac, among
other modifications, plays a key role in enhancer activation and gene expression.
Furthermore, the presence of H3K27ac without modifications frequently found at
enhancers (H3K4me1) demonstrated similar expression levels to regions containing both
H3K27ac and H3K4me1 (Creyghton et al., 2010). Together, these studies provide strong
evidence to support that H3K27ac is involved in activating gene expression across the
genome.

Histone Methylation: H3K4me1, H3K4me3, & H3K27me3
Similar to histone acetylation, histone methylation was first explored in the
1960’s (Allfrey et al., 1964; Murray et al., 1964), and the enzymes responsible for the
placement and removal of methyl groups have been well characterized. Lysine
methyltransferases (KMTs) are the enzymes responsible for adding methyl groups to
lysine residues in histone tails, such as H3K4 and H3K27. KMTs such as SETD1A/B,
MLL1-4, SETD7, and PRDM9 are responsible for mono- and tri-methylation of
H3K4me3, and EZH1 & EZH2, within the polycomb repressive complex 2 (PCR2), are
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involved in trimethylation of H3K27me3 (Husmann & Gozani, 2019). Methyl groups are
transferred from other molecules, such as S-adenosyl-L-methionine, to the lysine residues
(Kwon et al., 2003). Removal of the methyl groups is performed by lysine demethylases,
of which two types exist: LSD demethylases and JMJC demethylases (Kooistra & Helin,
2012). LSD demethylases, including LSD1, can remove mono- and di-methylation at
H3K4 and H3K9 (Shi et al., 2004; Kooistra & Helin, 2012), but are incapable of
removing trimethylation. JMJC demethylases, including RBP2 and JMJD3, remove
trimethylation at lysine residues, including H3K4 and H3K27 (Christensen et al., 2007;
De Santa et al., 2007; Lan et al., 2007). The placement and number of methyl groups
added to histone tails is tightly regulated and involved in both gene activation and
repression.
H3K4me3 are associated with active promoters and has been identified at the TSS
of genes across multiple species (Santos-Rosa et al., 2002; Schneider et al., 2004; The
ENCODE Project Consortium, 2007; Barski et al., 2007; Schuettengruber et al., 2009).
Santos-Rosa et al. (2002) suggested that H3K4me3 was present at the promoter of active
genes and absent from inactive genes in yeast; however, this pattern does not hold true in
humans. A study by Barksi et al. (2007) identified H3K4me3 marks associated with
TSSs, some enhancers, and silent promoters. Over 90% of the genome found to be
associated with RNA polymerase II also overlapped H3K4me3 (Barski et al., 2007).
Additional research supports the presence of H3K4me3 at both active and inactive
promoters (Schneider et al., 2004). Barksi et al. (2007) also identified colocalization of
H3K4me3 with repressive H3K27me3, which resulted in lower expression at these loci.
Although most studies have identified H3K4me3 to be enriched at active promoters, there
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is mixed evidence as to whether H3K4me3 can predict the activity of the genes to which
it localizes (Schneider et al., 2004; Barski et al., 2007).
Most studies have not shown a direct role of H3K4me3 on transcription, but
rather an indirect role through the recruitment of chromatin remodeling enzymes and
transcription factors, such as CHD1 and NURF (Lee et al., 2004; Flanagan et al., 2005;
Sims III et al., 2005; Li et al., 2006; Parvi et al., 2006; Wysocka et al., 2006; Sims III et
al., 2007). An indirect role of H3K4me3 also supports previous observations of
H3K4me3 at both active and inactive promoters (Schnieder et al., 2004; Barski et al.,
2009). Although H3K4me3 alone may not be indicative of active expression, H3K4me3
is a useful mark for identifying promoters.
H3K4me1 has also been identified at promoter regions (Barski et al., 2007).
H3K4me1 is often found in a bimodal pattern around the TSS of active genes (Barski et
al., 2007; Heintzman, et al., 2007; The ENCODE Project Consortium, 2007; Bae et al.,
2020); however, Cheng et al. (2014) demonstrated that H3K4me1 may have repressive
properties when occupying the TSS in the absence of H3K4me3, and Bae et al. (2020)
determined H3K4me1 to predict poised promoters when present at the TSS in a unimodal
pattern. Distal enhancer regions are commonly occupied by H3K4me1 with H3K4me3
less abundant at these loci (Heintzman et al., 2007; Heintzman et al., 2009; Creyghton et
al., 2010). The presence of H3K4me1 is highly cell type specific (Koch et al., 2007;
Heintzman et al., 2009), which may contribute to variation in the number and location of
H3K4me1 marks identified across studies. Active enhancer regions can also be inhabited
by H3K27ac which is likely due to the interaction of the enzymes that deposit H3K4me1
(MLL3/MLL4) and H3K27ac (CBP/p300) (Zhang et al., 2020; Lai et al., 2017); however,
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the presence of H3K27ac is not required for H3K4me1 marked enhancers to be active
(Creyghton et al., 2010; Zhang et al., 2020). Similar to the function of H3K4me3,
H3K4me1 modulates transcription through the binding of chromatin remodeling enzyme,
such as BAF (Local et al., 2018). In addition to BAF, H3K4me1 modulates the
recruitment of the cohesion complex which is directly involved in enhancer promoter
interactions (Kagey et al., 2010; Yan et al., 2018). H3K4me1 is a useful marker for
identifying enhancers in the genome, especially since these active regions can lie
thousands of base pairs away from the genes they regulate (Heintzman et al., 2007).
Unlike the previously discussed histone modifications, H3K27me3 is primarily
associated with repressed, or transcriptionally silent regions of the genome (Boyer et al.,
2006; Barski et al., 2007; Hosogane et al., 2016). H3K27me3 can also be present with
activating marks, such as H3K4me3, to create bivalent or poised promoters (Berstein et
al., 2006); however, PCR2, the enzyme that deposits H3K27me3, is suppressed by
activating histone marks, such as H3K4me3 and H3K27ac (Schmitges et al., 2011). As
with the other histone methylation, H3K27me3 impacts transcription through the
recruitment of chromatin remodeling enzymes. H3K27me3 attracts cPRC1 and BAH
which induce chromatin compaction and create regions of facultative heterochromatin
(Bierne et al., 2009; Grau et al., 2011; Isono et al., 2013). Facultative heterochromatin
refers to condensed regions of the genome associated with H3K27me3 and silenced genes
(Bierne et al., 2009). Unlike constitutive chromatin that exists at the centromere and
telomeres, facultative heterochromatin is more dynamic. Regions silenced by H3K27me3
cover broad ranges of the genome as binding of PCR2 to H3K27me3 increases deposition
of H3K27me3 in the surrounding histones until active regions are reached (Oksuz et al.,
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2018; Schmitges et al., 2011). Proper regulation of polycomb repression is imperative to
both embryonic development and the maintenance of adult stem cells (Boyer et al., 2006;
Lee et al., 2006; Bogliotti et al., 2012; Koppens et al., 2016). Although other histone
modifications are involved in gene repression, H3K27me3 is the most commonly assayed
modification for identifying repressed regions of the genome.
The presence of all four histone modifications, H3K27ac, H3K4me3, H3K4me1,
and H3K27me3, can be examined independently to quantify enhancers, promoters, and
silencers; however, the overlap of these histone modifications is often assessed to create a
comprehensive atlas of chromatin states. This method can be particularly helpful in
determining the activity levels of regulatory elements, as many studies have concluded
that “active” marks such as H3K4me3 and H3K4me1 can be found in both active and
inactive promoters and enhancers (Schnieder et al., 2004; Parvi et al., 2006; Barski et al.,
2009). The ENCODE project was one of the first studies to assess these four histone
marks across a range of cell lines. This project has established a foundation for the
methods of assessing such histone marks and has provided immense support for the value
of exploring histone modifications.

The Role of ChIP-seq in Functional Annotation
Two main methods were used to assess histone modifications in the ENCODE
project: ChIP-chip and ChIP-seq (Figure 1.3). Chromatin immunoprecipitation (ChIP)
allows for the identification of DNA-protein interactions by crosslinking the DNA and
protein. The DNA is then sheared to create small fragments that can be bound by
antibodies specific to histone modifications. These antibodies are used to pull down the
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DNA sequences associated with the
histone modification after which the
crosslinking is reversed. The only
difference between ChIP-chip and
ChIP-seq is how the DNA associated
with the histone modifications is
assessed. In ChIP-chip, the DNA
fragments are hybridized to
microarrays with a fixed number of
oligo binding sites. ChIP-seq employs
next generations sequencing which can
allow for more precise mapping of
histone modifications due to the ability
of the reads to map to any location in
the genome. ChIP-chip and ChIP-seq
libraries are often corrected for noise
by using input samples that undergo
Figure 1.3. Library Preparation for ChIP-seq
Experiments
Proteins are cross-linked to DNA and chromatin
is isolated and sheared. Antibodies are used to
precipitate regions of DNA associated with
specific proteins. Cross-links are reversed and
DNA is purified and amplified for sequencing
using either next generation sequencing (NGS)
(ChIP-seq) or microarrays (ChIP-chip). Figure
created with BioRender.com

crosslinking and fragmentation, but not
immunoprecipitation. Both techniques
have been successfully employed by
the ENCODE project, and other groups
have determined both methods produce
quality libraries (The ENCODE
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Project Consortium, 2007; Ho et al., 2011; The ENCODE Project Consortium, 2012).
However, ChIP-seq is now the standard as next generation sequencing is well developed.
ChIP-seq is also capable of identifying a greater number of peaks and narrower peaks
than ChIP-chip (Ho et al., 2011). The results of ChIP-seq studies from the ENCODE
project have made a profound impact on the understanding of regulatory elements and
gene expression across the genome.
Through the integration of ChIP data, models that use histone modifications to
predict transcription and cis-regulatory elements have been developed (Wang et al., 2008;
Karlić et al., 2010; Dong et al., 2012). Using a set of 38 histone modifications, Karlić
(2010) created a model that could predict gene expression in CD4+ T-cells with a
Pearson correlation coefficient of r = 0.77. Using the same dataset, Wang (2008)
identified a ‘backbone’ of 17 histone modifications, including H3K4me1, H3K4me3, and
H3K27ac, that was positively correlated with gene expression. Further, Wang (2008)
identified a cluster of four modifications, including H3K9me2, H3K9me3, H3K27me2,
and H3K27me3, that was associated with gene silencing. Another study by Dong et al.
(2012) was able to predict gene expression with up to 83% accuracy in seven cell lines
using 11 histone modifications. While large sets of histone modifications can predict
gene expression with greater accuracy, Karlić (2010) demonstrated that a model based on
H3K27ac, alone, predicted gene expression with 72% accuracy. These studies clearly
demonstrate the value of histone modification data in prediction gene expression. The
ENCODE project takes these concepts a step farther to identify how various histone
modifications interplay to modulate the activity of cis-regulatory elements, such as
enhancer, promoters, and silencers.
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In the production phase of the ENCODE project, 12 histone modifications,
including H3K27ac, H3K4me1, H3K4me3, and H3K27me3, were assessed across 6 cell
lines (The ENCODE Project Consortium, 2012). One group identified 36,589 putative
enhancers marked by H3K4me1 in HeLa cells and 24,566 enhancers in K562 cells, yet
only 22% of enhancers were found in both cell lines (Heintzman et al., 2009). The
ENCODE Project Consortium (2012) assessed promoter-like, enhancer-like, and
repressive regions partially characterized by the presence of H3K4me3, H3K4me1, and
H3K27me3, respectively. ENCODE identified 339,124 enhancer regions, 70,292
promoter regions, and hundreds of thousands of quiescent or repressed regions across 46
cell lines (The ENCODE Project Consortium, 2012). Both Heintzman (2009) and the
ENCODE Consortium (2012) identified a large degree of cell type specificity across
chromatin states; however, repressive regions were most commonly found in all six cell
types, supporting previous studies that suggest the importance of H3K27me3 in
regulating genes involved in early development (The ENCODE Project Consortium,
2012; Boyer et al., 2006). Together, these studies demonstrate the value of examining
histone marks in relation to genome function.
Overall, the ENCODE project identified evidence of over 80% of the genome
participating in biochemical reactions related to transcription and chromatin function
(The ENCODE Project Consortium, 2012). The project depicted the pervasive nature of
transcripts and regulatory elements in the genome. Further, the ENCODE project
demonstrates the need for assessing regulatory elements on a tissue-by-tissue basis. The
wealth of knowledge derived from the ENCODE project has vastly improved the study of
human genomics; however, as depicted in the study, gene activity and regulatory
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elements are not reliably conserved across tissues and species. Therefore, projects to
functional annotation genomes of other species have followed in the footsteps of the
ENCODE project.

The Functional Annotation of Animal Genomes (FAANG) Project
The FAANG consortium was established in 2014 with the intent of functionally
annotating the genomes of domestic species. The broad aim of the project is to enhance
the understanding of how the genome contributes to phenotype (The FAANG
Consortium, 2015). Similar to the ENCODE project, the FAANG project was intended
to be, and is, highly collaborative. Open access data portals have been generated to allow
for easy access of datasets as they are produced (FAANG.org). The project began with
groups of researchers dedicated to studying livestock species, such as cattle, sheep, pigs,
and chickens (The FAANG Consortium, 2015). To allow for interspecies comparisons,
key tissues and assays were selected to provide a standardized core of research on each
species. Key tissues that were prioritized include skeletal muscle, adipose, liver, and
tissues from the reproductive, immune, and nervous systems (The FAANG Consortium,
2015). The core assays include RNA-seq, ChIP-seq of H3K4me1, H3K4me3, H3K27ac,
and H3K27me3, and ATAC-seq (assay for transposase-accessible chromatin sequencing)
(The FAANG Consortium, 2015). Since its establishment in 2014, the FAANG project
has grown to include many other species. Research groups specific to cattle (Fang et al.,
2019), sheep (Davenport et al., 2021), pigs (Pan et al., 2021), chickens (Kern et la.,
2021), various farmed fish, and horses (Kingsley et al., 2020) have been successfully
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bolstering the knowledge of genomic function in important domestic species, yet most of
these projects are still underway. Such is the case with the equine FAANG project.
The genomic resources available for the horse provide a starting point for
genomic research into equine health and performance. Yet, limitations in the annotation
of the reference genome have repeatedly demonstrated the need for functional annotation
of the equine genome. The work outlined below aims to fulfil these needs and represents
a portion of the results from the equine FAANG project. The use of RNA-seq and ChIPseq in identifying gene expression and regulation in two Thoroughbred stallions will be
discussed in detail. The results of this research will allow for functional characterization
of the genome across eight different tissues and will provide an invaluable resource to the
equine community.
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CHAPTER 2: CHARACTERIZING THE TRANSCRIPTOME OF EIGHT TISSUES IN
HEALTHY THOROUGHBRED HORSES
Introduction
Mammalian genomes contain approximately 20,000 protein coding genes with up
to twice as many non-coding transcripts (Frankish et al., 2021). Many of these genes and
transcripts are differentially expressed across cell types to allow for diverse biological
functions throughout the body. Beyond normal tissue function, genes can be differentially
expressed in response to environmental stimuli and to allow for sexual dimorphism. To
determine changes in transcription under various conditions, an understanding of normal
gene expression in healthy tissues is imperative. Thus, many studies in humans have
aimed to characterize normal gene expression across a variety of cells and tissues.
Assessing more than 50 cell lines and tissues, together, many groups have
characterized genes commonly expressed across tissues and those exclusive to one or a
few tissue types in humans (Ramsköld et al., 2009; Djebali et al., 2012; Melé et al.,
2015). Ramsköld and others (2009) identified between 11,000 and 15,000 genes
expressed in each of 16 assayed tissues. Over 8,000 genes were ubiquitously expressed in
the 16 tissues, yet tissues such as the testis and brain expressed over 6,000 genes beyond
those ubiquitously expressed, many of which were unique to either the brain or testis
(Ramsköld et al., 2009). Similarly, Melé et al. (2015) found thousands of genes
differentially expressed across 43 human cell types and tissues. Further, The ENCODE
project suggests that as many as 7% of protein coding genes and 29% of long non-coding
RNAs (lncRNAs) were specific to one of 15 studied human cell lines (Djebali et al.,
2012). Together, these studies demonstrate the vast number of genes expressed across
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tissues. As the number of genes determined to be ubiquitously expressed or cell-type
specific is highly dependent on the tissues being studied, the transcriptome of a species is
best characterized through the examination of a variety of tissues.
Although sex may play a lesser role in differential gene expression than tissue
type, a significant number of genes are differentially expressed across sexes. One study
identified 92 protein coding genes and 43 lncRNAs that demonstrated global sex-biased
expression across 43 human cells and tissues with many of the differentially expressed
genes residing on the sex chromosomes (Melé et al., 2015). Another 753 tissue-specific
genes also demonstrated sex-biased gene expression (Melé et al., 2015). Over 6,500
genes were differentially expressed by sex in at least one of 53 human tissues, yet only a
small number of genes were differentially expressed due to sex in all tissues (Gershoni &
Pietrokovski, 2017). Many organs, such as the brain and heart, exhibit a large degree of
sex-biased gene expression, suggesting the importance of accounting for both tissue type
and sex in study design (Mayne et al., 2016). In the cases where multiple tissues cannot
be examined or sex cannot be balanced between treatment groups, understanding how
tissue type and sex impact gene expression in healthy tissues can be valuable for
removing bias from applied differential expression analyses.
Although the transcriptome has been well characterized in a variety of tissues in
humans, studies characterizing the transcriptome of a variety of healthy tissues is lacking
in the horse. Most transcriptome studies in the horse have been used to aid the annotation
of the equine genome, thus many projects examined a limited number of tissues or pooled
many tissues to generate only a single transcriptome (Coleman et al., 2010; Hestand et
al., 2015; Pacholewska et al., 2015). As part of the equine Functional Annotation of
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Animal Genomes (FAANG) project, this work aims to provide a resource describing the
transcriptome of seven common tissues, testis and ovary in healthy, adult Thoroughbred
horses. To do so, we generated poly-A+ RNA-seq libraries for adipose, parietal cortex,
left ventricle of the heart, lamina, liver, lung, skeletal muscle, and testis from two healthy
Thoroughbred stallions. These data were combined with similar libraries from two
healthy Thoroughbred mares to characterize the transcriptome in healthy tissues and
identify differentially expressed genes across sexes. This project was designed to provide
needed insight into normal gene function of commonly studied tissue types and to be
publicly available for use in equine genetic studies.

Materials and Methods
RNA Isolation
Tissues were provided by the FAANG biobank and were collected from two
Thoroughbred stallions between the ages of three and four years old (Donnelly et al.,
2021). The methods used to collect and store tissues are described in Donnelly et al.
(2021); in brief, samples utilized for RNA-sequencing were flash frozen in liquid
nitrogen and stored at -80C until RNA isolation. Of the 102 tissues in the biobank, 8
tissues, including those prioritized by the FAANG Consortium (The FAANG
Consortium, 2015) and those important to equine health, were chosen for study including
abdominal adipose, parietal cortex, left ventricle of the heart, lamina, liver, left lung,
Longissimus dorsi muscle, and left testis. All surfaces and tools were cleaned with
RNAseZap (Invitrogen, Waltham, Massachusetts) to reduce RNAses in the workspace.
Approximately 70mg of each tissue (100mg of adipose) was minced with a razor on dry
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ice. Tissue samples were then homogenized in 1ml of Trizol (Invitrogen, Waltham,
MA, USA) using a Kinematic Polytron (Luzern, Switzerland) on ice in 30 second
bursts. After homogenization, the samples were incubated at room temperature for 5
minutes before the addition of 200L of chloroform. Tough tissues, including adipose
and testis, were incubated for 10 minutes or more at room temperature before undergoing
a dirty spin. For the dirty spin, the adipose and testis samples were centrifuged at 12,000
x g for 10 minutes, and the supernatant was transferred to a clean 2.0mL tube before the
addition of chloroform. After the addition of chloroform, the samples were vortexed,
incubated for 2-3 minutes at room temperature, and spun at 12,000 x g for 15 minutes.
The clear supernatant of each sample was added to 600mL of ethanol and placed on a
spin column. RNA was isolated using the Zymo Research Direct-zol RNA Miniprep kit
(Irvine, CA, USA) according to manufacturer guidelines with minor revisions as
described. DNA was removed from samples using a 15 minute on-column DNase I
treatment. In addition to the 1-minute spin outlined in the Zymo protocol, the columns
were spun for an additional two minutes before elution in DNase/RNase free water to
remove any residual wash buffers. The speed and number of bursts used to homogenize
samples, their elution volume, and the presence of additional steps are recorded in Table
2.1. RNA was quantified using an Agilent Bioanalyzer 2100 Eukaryote Total RNA Nano
chip (Santa Clara, CA, USA) and RNA integrity (RIN) values were used to determine
RNA quality.

RNA Libraries from two Thoroughbred Mares
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Tissues from two healthy Thoroughbred mares between the ages of four and five
years old were previously collected for the equine FAANG project (Burns et al., 2018).
The sequencing data corresponding to RNA isolated from the same tissues in two mares,
with ovary replacing testis, were retrieved from the European Nucleotide Archive (ENA)
under project PRJEB26787. These data are also available in the FAANG data portal
under BioSampleIDs SAMEA104728877 and SAMEA104728862. The protocol used to
isolate RNA from the mare tissues is similar to what is described above. The mare data
consisted of 125bp paired-end, stranded, poly(A+) selected libraries (Illumina TruSeq).

Data Analysis
RNA from the stallion tissues was sent to Admera Health (South Plainfield, NJ,
USA), prepped using the TruSeq kit (Illumina, San Diego, CA, USA), and sequenced on
a NovaSeq 6000 Sequencing System (Illumina, San Diego, CA, USA). Libraries include
stranded, poly(A+) selected 150 bp paired-end reads. After data were received, adaptors
were removed and reads were trimmed using Trim-Galore (Kruger, 2019) and Cutadapt
(Martin, 2011). FastQC (Andrews, 2010) and mutliQC (Ewels et al., 2016) were used to
assess read quality. Trimmed reads were mapped to the EquCab3.0 reference genome
using STAR aligner (Dobin et al., 2013) under the default parameters. PCR duplicates
were marked with sambabma (Tarasov et al., 2015), and mapping rates, qualities, and
read lengths were assessed with samtools (Li at al., 2009) and deeptools (Ramírez et al.,
2016). The generated bam files were filtered to remove unmapped reads, alternative
alignments, PCR or optical duplicates, and reads that failed Illumina quality checks using
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samtools (Li et al., 2009). Further, reads were selected to include only those that were
mapped and properly paired.

Gene Expression Profiles and Pathway Analysis
The transcripts corresponding to each gene were quantified using Subread’s
featureCounts (Liao et al., 2014). The Refseq annotation of EquCab3.0
(GCF_002863925.1) was used to quantify the expression of 30,647 genes. Transcripts
were counted as pairs and required to be at least 49bp in length. Gene length was
determined by featureCounts using the length of the gene’s exons and transformed to
transcripts per kilobase million (TPM) to account for both gene length and sequencing
depth. TPM was calculated by first determining the reads per kilobase (RPK) for each
gene. RPK was calculated by dividing a gene’s read count by its length in kilobases. The
RPK of each gene was summed and divided by 1 million to get a scaling factor for each
sample. The RPK values were then divided by the sample’s scaling factor to get TPM.
Genes were considered expressed in an individual if greater than 10 TPM were
found at that locus. This threshold is considered “medium expression” by the European
Bioinformatics Institute’s Expression Atlas (EMBL-EBI, Hinxton, Cambridgeshire, UK;
https://www.ebi.ac.uk/gxa/FAQ.html#). In the case of the ovary and testis, genes were
considered expressed if both biological replicates from the corresponding sex expressed
the gene at greater than 10 TPM. Comparisons of gene expression across the remaining
tissues was performed with genes expressed at greater than 10 TPM in all four biological
replicates. Genes were considered expressed in only one sex if expression was greater
than 10 TPM in both replicates of that sex and below 1 TPM in both replicates of the
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opposite sex. Highly expressed genes were defined as genes with greater than 1000 TPM,
again, following the guidelines outlined by EMBL-EBI’s Expression Atlas (Hinxton,
Cambridgeshire, UK; https://www.ebi.ac.uk/gxa/FAQ.html#). Genes expressed in all
biological replicates for a given tissue were analyzed for KEGG pathway enrichment
using David Bioinformatics Database’s Functional Annotation Tool (Huang et al., 2009a;
Huang et al., 2009b). The gene names were converted to Entez gene IDs by the David
Bioinformatics Database, and the background list was the default for Equus caballus.
Significantly enriched KEGG pathways were defined as having a false discovery rate
(FDR) of less than 0.05.

Differential Expression Analysis
Differential expression analysis was performed using the raw read counts
generated by featureCounts (Liao et al., 2014). The R package, DESeq2 (Love et al.,
2014), was used for the analysis. Comparisons were made across sexes within each tissue
with female expression considered reference. Genes with fewer than 10 transcripts
identified across all individuals were discarded to remove genes with little or no
expression in a given tissue. Differentially expressed genes were filtered to maintain only
those with an Benjamini-Hochberg adjusted p-value of less than 0.05. Differentially
expressed genes were categorized as overexpressed in the stallions if the log 2 fold change
was positive and overexpressed in the mares if the log2 fold change was negative.

Results
RNA Quality, Read Annotation, and Data Availability
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The two stallion replicates are denoted as AH3 and AH4. The RIN values for the
stallion samples ranged from 7.6 to 9.7 with an average of 8.8 (Table 2.2). The
sequencing depth, including the mare libraries, ranged from 28.3 million to 73.3 million
paired reads. The average sequencing depth across both mares and stallions was 39.4
million paired reads. The bam files generated for this project can be accessed at
https://equinegenomics.uky.edu/faangHorses_RNASeq.html. On average, 92.9% of reads
mapped to a single location in the genome. After filtering to remove PCR duplicates,
unmapped reads, and low-quality reads, the average library across mares and stallions
consisted of 25.2 million read pairs.

Gene Expression Profiles
An average of 72.6% of uniquely mapped read pairs were assigned to genes
within the EquCab3.0 RefSeq annotation, while an average of 23.4% of read pairs
mapped outside of annotated exons. The total number of gene-assigned reads ranged
from 6.8 million reads in a mare heart sample to 31.1 million reads in a mare brain
sample. On average, each sample had 18.1 million reads assigned to annotated genes.
The number of genes expressed varied by tissue, but on average, 8,068 genes
displayed at least medium expression (>10 TPM) across tissues (Figure 2.1). Skeletal
muscle expressed the fewest genes at 6,330 or 21% of the genes in the RefSeq
annotation. The greatest number of genes expressed in a tissue shared across all replicates
were found in the brain. The brain expressed 9,884 genes comprising 32% of the genes in
the RefSeq annotation. The testes and ovaries expressed 10,604 and 8,922 genes,
respectively. Excluding reproductive tissues, the greatest number of sex-specific genes
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were identified in the female brain followed by the female liver with 27 and 13 genes,
respectively (Supplementary Table 2.1). Together, 11,115 genes were expressed across
the nine studied tissues comprising 36.2% of annotated genes. There were 4,218 genes
expressed in all nine tissues with 4,700 genes expressed at greater than 10 TPM in only
one studied tissue. Adipose had the fewest tissue-specific genes at 58 while the testis had
the greatest number of tissue-specific genes at 2,288 (Figure 2.1).
Genes with high levels of expression (> 1000 TPM) were also examined. On
average, each tissue had 88 genes that were highly expressed. The heart had the greatest
number of highly expressed genes at 132 genes and the brain the fewest (35 genes). Each
tissue had a small number of highly expressed genes unique to that tissue. The greatest
number of tissue-specific, highly expressed genes were found in the liver, with the fewest
found in the lamina. There were 93 highly expressed genes unique to the liver and only 6
highly expressed genes unique to the lamina (Table 2.3). The unique, highly expressed
genes frequently had functions specific to that tissue type, such as complement genes
(C1S and C1R) in the liver, keratin 14 (KRT14) in the lamina, and synaptosome
associated protein 25 (SNAP25) in the brain (Supplementary Table 2.2). Only two genes
were highly expressed across all nine tissue types: miRNA-703 (MIR703) and tumor
protein, translationally-controlled 1 (TPT1).

KEGG Pathway Enrichment of Expressed Genes
Pathways were considered enriched if the FDR was less than 0.05. Each tissue
had between 130 and 182 enriched pathways (Table 2.4). Ninety-eight of these pathways
were enriched in all studied tissues. The number of pathways unique to a tissue ranged
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between zero and 23 (Table 2.4). The liver and brain had the most unique pathways with
23 unique to the liver and 18 unique to the brain. No pathways were unique to lamina or
muscle. Pathways unique to a tissue are often specific to that tissue’s function. Genes
involved in the regulation of lipolysis in adipocytes were enriched in the adipose, and
genes involved in three cardiomyopathy pathways were enriched in the heart. The
pathways shared between all 9 tissues and those unique to only a single tissue can be
found in Supplementary Table 2.3.

Sex-Based Differential Expression Analysis
To understand the impact of sex on gene expression, genes differentially
expressed between mares and stallions were assessed in each of the seven shared tissues
(Figure 2.2). The tissue with the most differentially expressed genes was adipose in
which 1,765 genes were overexpressed in the stallions and 1,617 genes were
overexpressed in the mares. The lung had the fewest differentially expressed genes with
27 overexpressed in the stallions and 10 overexpressed in the mares (Figure 2.2). Only
four genes were differentially expressed across all 7 shared tissues including HLA class I
histocompatibility antigen, alpha chain G (HLA-G), centriole and centriolar satellite
protein (OFD1), an uncharacterized pseudogene (LOC111771383), and an
uncharacterized ncRNA (LOC102150010). HLA-G, OFD1, and LOC102150010 were
also differentially expressed between the testis and ovaries. HLA-G, OFD1, and
LOC111771383 were all overexpressed in the stallions while LOC102150010 was
overexpressed in the mares. All genes differentially expressed between sexes were
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identified in at least two tissue types. The genes with the greatest log2 fold change in
expression between mares and stallions are displayed in Supplementary Tables 2.4.
A principal component analysis was performed in DESeq2 to assess clustering
among samples. Regardless of which tissue was used as the reference for gene
expression, the principal component plot remained static. All samples clustered closely
based on their tissue type, but sex appeared to have a minimal impact on clustering
(Figure 2.3). The first principal component accounted for 42% of the variability between
samples and parsed liver, heart, and muscle from the remaining tissue types. The heart
and muscle samples clustered relatively closely, but the liver samples were isolated. The
second principal component accounts for 24% of the variability among samples and
further separated the heart, muscle, and liver samples. Tissues that remained closely
clustered include adipose, brain, ovary, testis, lamina, and lung.

Discussion
Characterizing the transcriptome is valuable for directing genomic studies;
however, the number of genes identified as expressed can be highly dependent on the
tissues examined and the definition of expression. In a study examining 24 tissues in
mice and humans, 60-70% of annotated genes were expressed at greater than 0.3 reads
per kilobase million (RPKM) (Ramsköld et al., 2009). In this study, only 36% of
annotated genes in the equine genome were considered expressed across nine tissue
types. Due to the low power resulting from the small number of biological replicates in
this study, the threshold for gene expression was set at a conservative 10 TPM to increase
the likelihood that the genes transcribed in the studied tissues would be representative of
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genes expressed in that tissue in all adult horses. The drastic difference between the
percentage of genes expressed across tissues between this study and Ramsköld's study
can be partially explained by the differences in the number of tissues examined, the
threshold for expression, and an increase in gene annotation in the last decade. Further,
the different methods used to normalize read counts can impact the ability to compare
relative gene expression across tissues.
Both RPKM and TPM correct for sequencing depth and gene length (Zhao et al.,
2021). Correcting for these factors is important because a larger total read count will
increase the number of transcripts that map, and longer transcripts often create more
fragments during library preparation which will increase the number of reads aligning to
those genes. However, RPKM and TPM are not the same. Unlike RPKM, the total count
of TPM adjusted transcripts is the same across samples which improves the ability to
compare gene expression across samples within a study; however, direct comparisons of
gene expression across studies can be limited by differences in library preparation (Zhao
et al., 2020). Although there are limitations to all normalization methods (Zhao et al.,
2020; Zhao et al., 2021), TPM was chosen to allow for comparison across tissues in this
study.
On average, 8,068 genes were identified to be expressed across the assayed
tissues. The fewest genes were expressed in the Longissimus dorsi with the greatest
number of genes expressed in the testis and then the brain. Each tissue in this study
expressed 20-35% of the genes in EquCab3.0 RefSeq annotation. Ubiquitously expressed
genes made up a large proportion of the genes expressed in each tissue. The majority of
the genes expressed in the muscle (67%), heart (60%), and liver (57%) where genes that

50
were ubiquitously expressed. The testis and brain had the smallest percentage of genes
that were ubiquitously expressed, 40% and 43%, respectively, and the largest proportion
of genes that were tissue-specific. These findings mirror those found by Ramsköld and
others (2009) in which skeletal muscle had the fewest expressed genes and the testis had
the greatest number of expressed genes. Ramsköld also found the transcriptomes of
skeletal muscle and liver to consist largely of ubiquitously expressed genes while the
testis and brain had a greater variety of expressed genes (Ramsköld et al., 2009).
A small proportion of genes were highly expressed across the studied tissues.
Two genes, however, were highly expressed in all nine tissues: miRNA-703 and TPT1.
miRNA-703 has been identified to protect cells from inflammasome-induced pyroptosis
following hypoxia in myocardial infarction (Wei et al., 2020). It is possible that MIR703
expression was upregulated in tissues due to hypoxia after euthanasia. TPT1 encodes the
fortilin protein that demonstrates strong anti-apoptotic effects (Li et al., 2001; Pinkaew et
al., 2017). It was previously found to be ubiquitously expressed in healthy tissues (Li et
al., 2001). Some highly expressed genes that were found in one of the studied tissues
have previously been identified to be tissue-specific in other species. For example,
adiponectin (ADIPOQ), fatty acid binding protein 4 (FABP4), and adipogenesis
regulatory factor (ADIRF) are all exclusively expressed or biasedly expressed in the
adipose tissue (Fagerberg et al., 2014).
In addition to uniquely expressed genes, enriched KEGG pathways were also
examined. The liver had the most uniquely enriched KEGG pathways. Fourteen of the 23
uniquely enriched pathways participate in the metabolism of various molecules which is a
known function of the liver. Of the seven uniquely enriched pathways in the lung, five
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were involved in immune function. The epithelial cells in the lungs are known to have a
large role in modulating the immune system (reviewed by Hewitt & Lloyd, 2021). Since
no other immune tissues were examined in this study, it is unsurprising that pathways
such as NF-𝜅𝐵, IL-17, RIG-I-like receptor, and toll-like receptor signaling are only
enriched in the lung tissue. Ninety-eight pathways were identified to be enriched in all
studied tissues. Many of these enriched pathways are involved in basic cellular function
and homeostasis, such as the cell cycle, apoptosis, endocytosis, RNA polymerase,
ribosomes, spliceosomes, and protein export. A large number of unexpected pathways
were enriched in all tissues, such as Alzheimer disease, Amyotrophic Lateral Sclerosis,
and Parkinson disease. It is hypothesized that many of these pathways are considered
enriched due to the presence of genes involved in the oxidative phosphorylation pathway
including ATP synthases, ATPases, NADH:ubiquinone oxioreductases, and cytochrome
c and b subunits. This depicts one of the limitations of KEGG pathway enrichment
analyses. Many pathways are named by the diseases they influence and include genes that
are broadly involved in basic cellular function. Nonetheless, the pathways that were
unique across tissues were informative of that tissue’s function and helped verify the
identity of the sampled tissue.
Genes expressed across tissues varied not only due to tissue type, but also due to
sex. Previous studies in humans have identified many genes exhibiting sex-biased
expression across a variety of tissues. Mayne and others (2016) identified over 2,000
genes differentially expressed due to sex across 15 tissue types. Another study identified
as much as 37% of genes displaying sex-biased gene expression among 44 tissues
(Meritxell et al., 2020). Some of the sex-biased gene expression can be contributed to
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regulatory elements with hormone response elements; however, approximately two-thirds
of genes displaying sex-biased expression do not contain hormone response elements
(Mayne et al., 2016). Even if the chemical processes leading to differential expression
across sexes are not fully understood, there is value in identifying these genes. These
differentially expressed genes may explain the differences in disease risk or efficacy of
drugs across sexes. Furthermore, understanding genes that are differentially expressed
due to sex can be used to identify potential bias in differential expression studies where
sex is not accounted for across treatment groups.
In our study, 923 genes were differentially expressed due to sex in at least one of
the nine studied tissues. Only four genes were differentially expressed across all nine
tissues: HLA-G, OFD1, LOC111771383, and LOC102150010. HLA-G is a gene encoding
part of the major histocompatibility complex. Previous studies have identified sex-biased
expression in HLA genes (Stein et al., 2021); however, Stein and others (2021) note that
accurate quantification of transcripts in HLA genes can be difficult due to the highly
polymorphic nature of these genes. These polymorphisms can impair the mappability of
transcripts to HLA genes. Therefore, the differential expression of HLA-G may reflect the
relatedness of biological replicates to the horse used for the reference genome rather than
differential expression due to sex. Both OFD1 and LOC102150010 are located on the X
chromosome. Although one X chromosome is generally inactivated in females, prior
research indicates that as many as 15% of genes on inactivated X chromosome are
expressed (Prothero et al., 2009). Therefore, it is possible that the overexpression of
LOC102150010 in females could be due to escape of X chromosome inactivation in the
females. Since LOC102150010 is an uncharacterized ncRNA in the horse, greater
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annotation of noncoding genes will be required to understand the impact of sex on this
ncRNA. OFD1 has been described to map to both the X and Y chromosomes in other
species (Chang et al., 2011). In cattle, OFD1Y was found to be expressed in a variety of
tissues (Chang et al., 2011). The overexpression of OFD1 in the stallions may reflect an
unannotated copy of OFD1 on the Y chromosome which is not currently apart of the
EquCab3.0 reference genome. LOC111771383 represents an uncharacterized pseudogene
on equine chromosome 23, and therefore, the potential reasons for differential expression
cannot be currently examined.
The degree of differential expression due to sex varied widely across tissues.
Adipose had 3,382 genes that were differentially expressed while the lung had only 37.
The three tissues with the greatest differential gene expression were adipose, muscle and
liver. Both adipose and skeletal muscle were also found to be highly differentially
expressed across sexes in a study of human tissues (Gershoni & Pietrokovski, 2017).
Understanding sex-biased gene expression is important when analyzing data from studies
including just one sex. Although some tissues such as lung and lamina have less sex-bias
in gene expression, commonly studied tissues related to athletic performance and
metabolic diseases have 900 or more genes that are differentially expressed across the
sexes (McGivney et al., 2010; Park et al., 2012; Ertelt et al., 2014; Ropka-Molik et al.,
2017). Therefore, it can be difficult to reliably extrapolate results generate in one sex to
the other and this result warrants examination of both sexes when considering the impact
of various stimuli on gene expression.
The data presented in this study provide a valuable resource to the equine
community. The gene expression profiles of nine healthy tissues are characterized which
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may be useful in informing researchers which tissues and sexes would be the most
beneficial to study regarding their research intents. For example, when examining
candidate mutations related to a disease that mainly impacts a single tissue, resources can
be focused towards mutations in genes that are expressed in the impacted tissue. While
the findings of this study are informative, the small sample size is a limitation of the
study. Although a conservative threshold for gene expression was employed to account
for this, the genes found to be expressed, and especially those differentially expressed
across sexes, may not be representative of the transcriptome present in all healthy adult
horses. Furthermore, only nine tissues were compared meaning that many of the genes
and pathways identified to be unique in this dataset may also be enriched in other tissues
that were not examined in this study. Nonetheless, this study provides a strong foundation
for the study of the equine transcriptome and will be valuable for informing the design of
applied research in the equine community.

Table 2.1. Tissue Homogenization and RNA Elution Specifications

Tissue
Abdominal Adipose (Adipose)
Parietal Cortex (Brain)
Heart Left Ventricle (Heart)
Lamina
Liver
Left Lung (Lung)
Longissimus dorsi (Muscle)
Left Testis (Testis)

Homogenization
Speed
Duration
(kRPM)
26-28
30 sec (x3)
10-12
20 sec (x2)
22-24
30 sec (x3)
22-24
30 sec (x3)
22-24
30 sec (x3)
22-24
30 sec (x3)
18-20
30 sec (x3)
22-24
30 sec (x4)

RT Incubation/
Dirty Spin

Elution
Volume

10 min: Yes
5 min: No
5 min: No
5 min: No
5 min: No
5 min: No
5 min: No
20 min: Yes

50uL
50uL
50uL
100uL
80uL
50uL
100uL
100uL
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Table 2.2. RIN Values of RNA Isolated From Stallion Tissues
Tissue
Adipose
Brain
Heart
Lamina
Liver
Lung
Muscle
Testis

AH3 RIN
8.4
9.5
8.3
8.8
9.4
8.0
8.8
9.7

AH4 RIN
8.5
9.1
7.6
8.7
9.4
8.4
9.2
9.7

12000

Number of Genes

10000
8000

6000
4000
2000
0
Adipose Brain

Expressed

Heart Lamina Liver

Ubiquitously Expressed

Lung Muscle Ovary

Testis

Uniquely Expressed

Figure 2.1. Genes Expressed by Tissue
The total number of genes expressed in a tissue across all four replicates (two replicates
for ovary and testis) is represented by the total height of the bar. Genes must be expressed
in all biological replicates for a gene to be considered expressed in a tissue. In the ovary
and testis, genes are considered expressed if both biological replicates of that sex express
a given gene. The genes in lightest blue are expressed in that tissue as well as in at least
one other tissue in the dataset. Genes in the medium blue are ubiquitously expressed
across all nine tissue types. Genes in the darkest blue were expressed at greater than 10
TPM in only that tissue.
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Table 2.3. Genes Highly Expressed (>1000 TPM) in All Biological Replicates Across
Tissues
Tissue
Highly Expressed Genes
Tissue-Specific High Expression
Adipose
92
11
Brain
35
16
Heart
132
45
Lamina
83
6
Liver
113
93
Lung
80
10
Muscle
122
38
Ovary
90
13
Testis
46
33

Table 2.4. Number of Enriched KEGG Pathways
Tissue
All Pathways
Unique Pathways
Adipose
182
1
Brain
172
18
Heart
154
3
Lamina
162
0
Liver
172
23
Lung
182
7
Muscle
133
0
Ovary
175
3
Testis
130
1
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Differentially Expressed Genes by Sex
2000

Number of DE Genes

1800

1765
1617

1600
1400
1200
1000
800
541

600
278

400
112

200

473 522
361

92

136

74

33

27

10

0
Adipose

Brain

Heart

Overexpressed in Stallions

Lamina

Liver

Lung

Muscle

Overexpressed in Mares

Figure 2.2. Differential Gene Expression Due to Sex
Differentially expressed genes (Padj < 0.05) across tissues due sex. Genes found to be
upregulated in males are in blue while the genes upregulated in females are in pink. The
number of differentially expressed genes is recorded at the top of each bar.
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Figure 2.3. Principal Component Analysis
A principal component analysis performed in DESeq2 following differential expression
analysis considering both sex and tissue types as factors. Samples cluster strongly by
tissue, but not by sex. Together, the first 2 principal components account for 66% of the
variability among samples.
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Supplementary Table 2.1. Genes Expressed in Only One Sex
Female Only

Male Only

Adipose

EDIL3, LOC102150010,
LOC111770938, PROKR1

EPM2AIP1, LOC100064259,
LOC106783151, LOC111771275,
LRAT, MIR9184, PRM1,
RSPH4A, SLC4A4

Brain

LOC100053403, LOC100053499,
LOC100053847, LOC102148406,
LOC102150010, LOC106782239,
LOC111769679, LOC111770252,
LOC111770264, LOC111770486,
LOC111770496, LOC111770499,
LOC111770515, LOC111770525,
LOC111770527, LOC111770531,
LOC111770545, LOC111770546,
LOC111770553, LOC111772707,
LOC111773021, LOC111773023,
LOC111774090, LOC111774512,
LOC111775847, MIR1543

None

Heart

None

MIR219-1, MIR8944, PRM1

Lamina

None

LOC100051724, LOC111767996,
LOC111770981

Liver

FZD10, LOC100055856,
LOC102148406, LOC102150010,
LOC111769679, LOC111769781,
LOC111770262, LOC111770497,
LOC111770545, LOC111770553,
LOC111774220, MIR8985,
MIR9041

LOC111772972

Lung
Muscle

None
LOC102148741

MIR1244
HBA, LOC111774862, PRM1
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Supplementary Table 2.2. Genes Highly Expressed in a Single Tissue
Adipose
Brain
Heart

Lamina
Liver

Lung
Muscle

Ovary

Testis

ADIPOQ, ADIRF, CAVIN1, DCN, G0S2, LGALS1, LOC100049811,
LOC100057425, PLIN1, RPS28, S100A1
APP, PLP1, ALDOC, CALM3, CPE, GLUL, MBP, NRGN, PEA15,
S100B, SNAP25, SPARCL1, THY1, UCHL1, YWHAE, YWHAH
ACTC1, CHCHD10, ATP2A2, ATP5MG, CYC1, CYCS, ACTN2,
ATP5MD, ATP5PB, ATP5PF, ACO2, ANKRD1, ATP5F1C, ATP5IF1,
ATP5MF, ATP5PD, BSG, FHL2, GNG5, HSPB7, LOC100055813,
LOC100630549, LOC100630564, LOC106781327, LOC106781507,
LOC111767815, MYBPC3, MYH7, MYL2, MYL3, MYOZ2, NDUFA4,
NDUFB2, NDUFB8, NDUFS2, NDUFS6, PDLIM1, PLN, PRDX2,
PSAP, SDHD, SMPX, TNNC1, TNNT2, VDAC3,
ANXA1, PERP, KRT14, S100A6, SFN, LOC100630872
AFM, AMBP, LOC100073265, LOC106782649, APOA2, CAT,
ALDH1L1, CYP2E1, CYP3A97, AGT, APOC2, APOH, ASS1, A1BG,
ALDH1A1, APOA1, APOC3, ASGR1, C1S, FGA, FMO3, GC, HRG,
ITIH2, ITIH4, LOC100034242, LOC100050685, LOC100053249,
LOC100060505, LOC100061234, LOC100061367, LOC100061692,
LOC100066603, LOC100067869, LOC100070616, LOC106782650,
LOC106782651, METTL7B, ACSL1, ALDOB, C1R, CDO1, CFB, CFI,
CYP2A13, AOX1, CPS1, LOC100071061, AHSG, APOB, CCL16, CRP,
CYB5A, DHRS7, DPYS, ECHS1, EPHX1, F10, F2, FGB, FGG, FN1,
GLUD1, GSTA1, HAAO, HAMP, HPD, HPX, HSD17B13, ITIH1,
KNG1, LECT2, LOC100051562, LOC100053468, LOC100056506,
LOC100059239, LOC100070400, MAT1A, PAH, PGRMC1, PLG,
RARRES2, RGN, RNASE4, SERPINC1, SERPIND1, SERPINF2,
SERPING1, SLCO1B3, TAT, TMBIM6, TTR, VTN
HSPA6, LOC100630171, LOC106781303, MARCO, NPC2, RGS2,
SCGB1A1, SEC14L3, SFTPA1, SFTPC
ACTN3, ADSSL1, AK1, ATP2A1, BIN1, CA3, CASQ1, CNBP, CSDE1,
EEF2, EIF4A2, GPD1, GPI, KLHL41, LDB3, LDHA, LOC100051065,
LOC100058290, MYBPC2, MYH1, MYL1, MYLK2, MYLPF, MYOT,
MYOZ1, PDLIM3, PFKM, PGK1, PGM1, PKM, PPP1R1A, PPP1R27,
SH3BGR, SLN, TMOD4, TNNC2, TNNI2, TNNT3
ENO1, GSTO1, HMGCR, HMGCS1, IGFBP7, LOC100065786,
LOC111775780, MIR675, MIR9182, MSMO1, PLA2GIB, PRDX1,
RPS15, STAR
AKAP4, CABYR, CMTM2, CRISP2, DKKL1, DNAAF1, DYNLL1,
GSG1, GSTM3, HAGH, HMGB4, INSL3, LOC100072403,
LOC100073295, LOC102147484, LOC102148276, OAZ3, ODF1,
ODF2, PABPC1, PRM1, PRM2, PSMD2, RAN, RPL38, SPA17,
STMN1, TNP1, TPPP2, TSACC, TUBB4B, WASHC3, YBX2
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Supplementary Table 2.3. Ubiquitously-Enriched and Tissue-Unique KEGG
Pathways
Tissue

All
Tissues

Enriched KEGG Pathways
Adherens junction, Adipocytokine signaling pathway, AGE-RAGE
signaling pathway in diabetic complications, Alzheimer disease,
AMPK signaling pathway, Amyotrophic lateral sclerosis, Apoptosis,
Autophagy - animal, Autophagy - other, Bacterial invasion of epithelial
cells, Basal transcription factors, Biosynthesis of cofactors, Carbon
metabolism, Cell cycle, Cellular senescence, Central carbon
metabolism in cancer, Chemical carcinogenesis - reactive oxygen
species, Choline metabolism in cancer, Chronic myeloid leukemia,
Citrate cycle (TCA cycle), Colorectal cancer, Coronavirus disease COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor
resistance, Endocrine resistance, Endocytosis, Endometrial cancer,
Epstein-Barr virus infection, ErbB signaling pathway, Fatty acid
degradation, Fatty acid metabolism, Fluid shear stress and
atherosclerosis, Focal adhesion, FoxO signaling pathway, Glioma,
Glucagon signaling pathway, Glyoxylate and dicarboxylate
metabolism, Hepatitis B, Hepatocellular carcinoma, HIF-1 signaling
pathway, Human cytomegalovirus infection, Human immunodeficiency
virus 1 infection, Human papillomavirus infection, Human T-cell
leukemia virus 1 infection, Huntington disease, Insulin resistance,
Insulin signaling pathway, Longevity regulating pathway, Longevity
regulating pathway - multiple species, Lysine degradation, Lysosome,
Metabolic pathways,
Mitophagy - animal, mRNA surveillance pathway, mTOR signaling
pathway, N-Glycan biosynthesis, Neurotrophin signaling pathway,
Non-alcoholic fatty liver disease, Non-small cell lung cancer,
Nucleocytoplasmic transport, Nucleotide excision repair, Oocyte
meiosis, Oxidative phosphorylation, Pancreatic cancer, Parkinson
disease, Pathways of neurodegeneration - multiple diseases, PD-L1
expression and PD-1 checkpoint pathway in cancer, Peroxisome, Prion
disease, Propanoate metabolism, Prostate cancer, Proteasome, Protein
export, Protein processing in endoplasmic reticulum, Pyruvate
metabolism, Regulation of actin cytoskeleton, Renal cell carcinoma,
Ribosome, Ribosome biogenesis in eukaryotes, RNA degradation,
RNA polymerase, Salmonella infection, Small cell lung cancer,
Sphingolipid signaling pathway, Spinocerebellar ataxia, Spliceosome,
T cell receptor signaling pathway, Terpenoid backbone biosynthesis,
Thermogenesis, Thyroid hormone signaling pathway, Tight junction,
Toxoplasmosis, Ubiquitin mediated proteolysis, Valine, leucine and
isoleucine degradation, Vasopressin-regulated water reabsorption,
VEGF signaling pathway, Viral carcinogenesis, Yersinia infection

62
Supplementary Table 3 (cont.)
Adipose

Brain

Heart
Lamina

Liver

Lung
Muscle
Ovary
Testis

Regulation of lipolysis in adipocytes
Glutamatergic synapse, Synaptic vesicle cycle, GABAergic synapse,
Morphine addiction, Cholinergic synapse, Circadian entrainment,
Aldosterone synthesis and secretion, Long-term depression,
Amphetamine addiction, Glycosaminoglycan biosynthesis - heparan
sulfate / heparin, Gastric acid secretion, GnRH secretion, cAMP
signaling pathway, Insulin secretion, Aldosterone-regulated sodium
reabsorption, Nicotine addiction, Alanine, aspartate and glutamate
metabolism, Fatty acid biosynthesis,
Hypertrophic cardiomyopathy, Dilated cardiomyopathy,
Arrhythmogenic right ventricular cardiomyopathy
None
Glycine, serine and threonine metabolism; Complement and
coagulation cascades, Tryptophan metabolism, Cholesterol metabolism,
Drug metabolism - other enzymes, Pentose and glucuronate
interconversions, Porphyrin metabolism, Drug metabolism cytochrome P450, Ascorbate and aldarate metabolism, beta-Alanine
metabolism, Histidine metabolism, Metabolism of xenobiotics by
cytochrome P450, Pantothenate and CoA biosynthesis, Riboflavin
metabolism, Chemical carcinogenesis - receptor activation,
Glycerolipid metabolism, Phenylalanine metabolism, Chemical
carcinogenesis - DNA adducts, Nicotinate and nicotinamide
metabolism, Tyrosine metabolism, Folate biosynthesis, Biosynthesis of
unsaturated fatty acids, Fatty acid elongation
NF-kappa B signaling pathway, Toll-like receptor signaling pathway,
Cell adhesion molecules, Rheumatoid arthritis, Transcriptional
misregulation in cancer, IL-17 signaling pathway, RIG-I-like receptor
signaling pathway
None
Glutathione metabolism, Selenocompound metabolism,
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan
sulfate
Pyrimidine metabolism
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Supplementary Table 2.4. The Top 20 Differentially Expressed Genes by Sex
Adipose

Brain

Mean
Female
Expression

log2
Fold
Change

P adj

36.80

8.74

5.1E-06

40.67

7.41

2.8E-03

13.36

7.27

6.4E-03

12.77

7.20

2.7E-03

12.68

7.19

1.1E-02

12.53

7.18

2.4E-03

383.97

7.11

8.8E-31

11.68

7.08

3.4E-03

11.01

6.99

6.1E-03

83.03

6.89

2.09E-05

SIM1

16.38

-7.39

3.2E-03

DIRAS1

49.05

-7.47

3.5E-03

TRHDE

17.84

-7.51

4.8E-03

LOC
106780963

150.85

-8.18

8.4E-11

HTR2A

87.18

-8.25

3.6E-02

NELL1

42.50

-8.77

1.1E-05

52.74

-9.08

5.7E-07

86.39

-9.79

4.4E-02

EGFL6

148.08

-10.57

3.1E-09

LOC
106781302

246.91

-24.65

1.1E-05

Gene ID
LOC
100064259
LOC
100056127
IYD
LOC
100072708
LOC
111769125
LOC
111774060
LRAT
LOC
111772591
LOC
111771275
LOC
106783067

LOC
102147462
KRT3

Gene ID
LOC
111775630
LOC
111774627
MYH2
LOC
111770337
LOC
100062546
CPLX4
LOC
100061551
LOC
100630497
LOC
100056099
LOC
111771597
LOC
111773712
LOC
111770452
LOC
100065590
LOC
102149722
LOC
111770904
LOC
100053403
LOC
100054521
MIR1543
LOC
102150010
LOC
111774090

Mean
Female
Expression

log2
Fold
Change

P adj

29.03

8.72

1.64E-05

29.98

7.33

2.66E-02

24.62

7.03

1.71E-03

23.46

6.94

2.75E-02

50.97

5.47

7.40E-07

16.58

5.44

3.69E-03

26.77

3.61

2.51E-03

27.75

3.51

4.55E-04

269.58

3.33

4.47E-04

50.60

3.10

4.81E-05

305.23

-7.24

1.11E-24

19.56

-7.31

1.87E-03

19.66

-7.32

2.34E-03

19.65

-7.32

1.83E-03

58.86

-7.45

1.36E-04

286.76

-7.74

4.81E-20

307.45

-7.84

1.52E-20

29.55

-7.91

4243.46

-8.76

1.15E-04
1.82E119

350.70

-11.48

3.83E-12

*Positive fold changes represent genes with greater expression in the stallions. Negative
fold changes represent genes with greater expression in the mares.

64
Supplementary Table 2.4. (cont.)
Heart

Lamina
log2
Fold
Change
4.25

P adj

Gene ID

HSPA6

Mean
Female
Expression
531.21

Mean
Female
Expression
1510.57

log2
Fold
Change
10.37

7.95E-20

SPTSSB

4.87E-02

PRUNE2

131.14

3.65

7.49E-09

9581.37

9.62

4.49E-02

47.43

9.34

8.97E-05

32.99

8.82

9.16E-04

42.06

7.74

1.80E-03

15.02

7.68

2.40E-02

195.48

7.14

2.56E-04

75.05

7.13

4.95E-02

2.45E-06

PRR9
LOC
111774465
LOC
111775630
LOC
111770981
ADAM7
LOC
111775638
LOC
111769006
SPOCK3

BCAT1

301.69

3.46

2.18E-09

226.31

3.40

8.31E-10

824.62

3.39

8.31E-10

144.65

3.18

7.49E-09

SPON1

137.75

3.01

1.99E-08

NR4A3

170.72

2.82

6.42E-04

CHRDL1

102.93

2.76

70.61

7.03

3.20E-02

SPHKAP
LOC
100062359
CISH

83.17

2.76

3.04E-04

LTF

22.72

6.81

2.09E-02

197.13

-2.01

1.34E-04

ACHE

261.30

-3.10

4.43E-02

357.81

-2.03

1.41E-07

44.52

-3.21

1.59E-02

FRZB

1023.51

-2.21

2.18E-09

302.81

-3.57

9.16E-04

OST4

100.86

-2.47

8.12E-05

31.59

-3.75

4.80E-02

CITED1

152.91

-2.50

5.87E-04

ACP7
LOC
100051371
LOC
100069585
PRKG2

42.14

-5.05

3.17E-02

TSPO
LOC
100146514
LOC
100050506

228.75

-2.54

9.19E-06

CYP2E1

121.98

-5.08

4.63E-02

105.53

-2.62

1.21E-04

STK32B

36.57

-5.27

2.55E-03

271.18

-2.63

5.28E-07

4481.73

-6.22

4.82E-38

THRSP

120.03

-3.23

3.02E-06

429.63

-7.28

1.67E-06

LOC
102150010

1255.41

-5.22

1.69E-05

66.82

-9.19

8.00E-04

Gene ID

LOC
111775969
LOC
100056099
CPXM2

LOC
102150010
LOC
102150085
P19

P adj

*Positive fold changes represent genes with greater expression in the stallions. Negative
fold changes represent genes with greater expression in the mares.
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Supplementary Table 2.4. (cont.)
Liver

Lung

Mean
Female
Expression

log2
Fold
Change

P adj

367.45

11.06

5.25E-11

68.48

10.08

1.38E-08

342.63

9.37

1.26E-02

11.80

7.54

1.69E-03

11.37

7.49

1.75E-03

10.09

7.31

3.34E-03

9.24

7.18

1.13E-02

FGF21

24.07

7.11

2.06E-02

PRM1

7.85

6.95

1.44E-02

GPX5

6.95

6.77

2.06E-02

15.17

-6.84

1.54E-02

414.84

-6.86

3.98E-33

15.51

-6.87

2.98E-03

405.06

-6.95

17.75

Gene ID
LOC
111772972
LOC
111770995
LOC
100064796
LOC
100629895
ADAM7
LOC
102150542
LOC
111775631

LOC
111772597
LOC
111773712
LOC
102148948
LOC
111770083
KCTD4
LOC
111770262
LOC
111773958
LOC
111769679
LOC
102150010
LOC
111774090

Mean
Female
Expression

log2
Fold
Change

P adj

21.40

8.18

6.12E-03

26.77

6.06

8.20E-03

23.17

5.85

1.47E-02

35.52

5.13

4.67E-04

35.86

4.62

1.77E-03

64.03

4.34

2.93E-04

64.46

4.26

1.30E-03

43.52

4.10

1.21E-02

54.54

4.01

2.61E-03

46.84

4.01

5.16E-04

2279.68

-2.14

1.58E-02

926.48

-2.21

4.47E-02

CRMP1

277.87

-2.56

1.03E-04

1.63E-32

GABRA3

234.70

-2.73

2.05E-04

-7.06

1.51E-03

LOC
111770338

140.00

-3.12

2.14E-02

18.95

-7.16

9.93E-04

CYP1A1

238.25

-3.18

2.05E-04

21.37

-7.33

5.32E-04

603.15

-3.55

8.86E-08

25.84

-7.61

2.00E-04

54.24

-3.83

6.23E-03

4108.12

-8.05

1.63E136

124.43

-4.31

2.05E-04

411.22

-8.58

2.68E-19

3441.89

-5.35

9.32E-18

Gene ID
LOC
111767996
LOC
111774465
LOC
106781675
LOC
111775630
LOC
100056585
LOC
111770981
LOC
100051724
LOC
111768886
LOC
111775343
LOC
111769025
LOC
111774782
LOC
100067178

LOC
100147051
LOC
100147109
LOC
100066745
LOC
102150010

*Positive fold changes represent genes with greater expression in the stallions. Negative
fold changes represent genes with greater expression in the mares.
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Supplementary Table 2.4. (cont.)
Skeletal Muscle

Ovary/Testis

Gene ID

Mean
Female
Expression

log2
Fold
Change

P adj

Mean
Female
Expression

log2
Fold
Change

P adj

NEFM

120.23

7.82

4.72E-02

NEFL

104.41

7.66

4.67E-05

LOC
100072403
GSG1

10138.70

16.69

3.06E-27

8381.28

16.42

2.20E-26

HSPA6
LOC
111771118
NEFH
LOC
111775630
NR4A3

476.03

7.57

3.89E-02

CRISP2

8300.23

16.41

2.07E-26

43.31

7.40

3.43E-02

PRM1

7439.17

16.25

6.72E-26

79.37

7.26

2.00E-04

CMTM2

7080.09

16.18

1.15E-25

31.93

6.94

1.22E-03

TNP1

6210.52

15.99

3.84E-25

543.36

6.24

2.71E-02

HMGB4

5506.54

15.81

1.38E-24

HBA

21.23

5.32

2.68E-03

PRM2

5217.67

15.74

2.39E-24

DSP
LOC
111769187
KHDRBS3

30.96

5.29

3.36E-03

PIWIL1

4721.97

15.59

6.16E-24

52.47

4.80

4.75E-04

ODF1

4449.61

15.51

1.15E-23

50.20

-3.19

4.25E-03

SLC5A7

55.55

-9.28

8.54E-07

CCKBR
LOC
111775091
KCTD16

71.36

-3.34

1.18E-03

GALNT5

55.77

-9.29

9.97E-07

27.44

-3.46

1.55E-02

PHLDA2

2157.34

-9.42

1.56E-21

147.45

-3.54

1.83E-10

426.31

-9.81

1.05E-02

SIX2

45.05

-3.85

1.27E-02

NTS
LOC
111768621

478.98

-9.96

2.54E-12

34.00

-4.77

3.30E-05

COL11A1

7328.34

-10.07

6.30E-20

298.71

-5.05

2.16E-36

1150.05

-12.22

1.95E-03

48.15

-6.62

3.72E-03

LOC
100050034
SERPINB2

613.55

-12.75

1.60E-02

30.41

-8.41

8.88E-05

CGA

3905.46

-12.95

4.48E-04

31.04

-8.44

1.11E-04

SPINK9

2201.24

-13.12

1.28E-03

LOC
102148741
LOC
102150010
HOXA11
LOC
102147462
LOC
111771163

Gene ID

*Positive fold changes represent genes with greater expression in the stallions. Negative
fold changes represent genes with greater expression in the mares.
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CHAPTER 3: FUNCTIONAL ANNOTATION OF PUTATIVE CIS-REGULATORY
ELEMENTS IN THE GENOMES OF TWO THORUGHBRED STALLIONS

Introduction
With an annual economic impact of $50 billion in the US alone, the equine
industry has long focused on improving the health and performance of horses (American
Horse Council, 2018). The role of genomics on traits such as racing ability, fertility, and
conformation have been widely studied since the release of the first equine reference
genome in 2007 (Wade et al., 2009; Hill et al., 2010; Raudsepp et al., 2012; SingerHasler et al., 2012). Varying degrees of success have met these studies as limitations in
the annotation of the equine genome have impaired identification of functional candidates
for many traits of interest. Similar difficulties have been observed in humans with as
much as 88% of trait-associated variants falling outside protein coding sequences
(Hindorff et al., 2009). Yet, the annotation of most genomes, including that of the horse,
is largely based on transcriptome data which primarily capture protein coding sequence
(Coleman et al., 2010; Hestand et al., 2015; Mansour et al., 2017). Therefore, using
additional methods to annotate the genome beyond protein-coding sequence may improve
the success of genomic studies into equine health and performance.
The human ENCODE project aimed to address similar shortcomings in the human
genome annotation. With the ambitious goal of identifying all functional elements in the
human genome, the ENCODE project attributed function to as much as 80% of the
human genome. Protein coding sequence comprised less than 3% of the human genome
indicating a large presence of other functional elements (The ENCODE Project
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Consortium, 2012). Despite the small footprint of protein coding genes in the genome, a
large portion of the genome is dedicated to regulating their expression. Cis-regulatory
elements aid in maintaining transcriptional programming and include promoters,
enhancers, and silencers. The ENCODE project identified nearly 400,000 enhancer
regions and 70,000 promoter regions in the human genome (The ENCODE Project
Consortium, 2012). The functional annotation performed by the ENCODE project and
subsequent research efforts have elucidated the impact of non-coding variants on disease
traits in humans. For example, an enhancer region variant was associated with coronary
artery disease and promoter region variants have been associated with schizophrenia and
various forms of cancer (Gupta et al., 2017; Warburton et al., 2016; Vinagre et al., 2013).
Together, these studies demonstrate the value of annotating regulatory elements
throughout the genome.
The Functional Annotation of Animal Genomes (FAANG) project aims to
functionally annotate the genomes of domesticated species to improve the understanding
of the genotype-to-phenotype link (The FAANG Consortium, 2015). Part of this effort
includes annotating regulatory elements through the use of chromatin
immunoprecipitation and sequencing (ChIP-seq). ChIP-seq of four histone modifications
associated with enhancers (H3K4me1), promotors (H3K4me3), active genomic regions
(H3K27ac), and repressed genomic regions (H3K27me3) has been prioritized as core
assays of the FAANG initiative. The equine FAANG project has previously characterized
these four histone modifications in a variety of tissues from two Thoroughbred mares
(Kingsley et al., 2020; Kingsley et al., 2021); however, regulatory elements have yet to
be characterized in the tissues of stallions. Our group identified thousands of genes
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differentially expressed between the tissues of mares and stallions indicating differences
in gene regulation across sexes. Indeed, differences in histone modifications have been
observed between sexes in other species demonstrating the need for annotating regulatory
elements in both sexes (Shen et al., 2015; Kfoury et al., 2021). This project aims to
characterize histone modifications in the tissues of two Thoroughbred stallions to allow
for a comparison of regulatory elements present in the tissues of mares and stallions.

Materials and Methods
Chromatin Extraction and Immunoprecipitation
Tissue samples from abdominal adipose, parietal cortex (brain), left ventricle
(heart), lamina, liver, lung, Longissimus dorsi (muscle), and testis of two Thoroughbred
stallions were prioritized for chromatin immunoprecipitation and sequencing (ChIP-seq)
analysis and retrieved from the equine FAANG Biobank (Donnelly et al., 2021).
Collected tissues had been flash frozen in liquid nitrogen and stored -80 ◦C (Donnelly et
al., 2021). ChIP preparation and sequencing was performed by Diagenode using their
ChIP-seq Profiling Service (Diagenode, Cat# G02010000, Liège, Belgium). Chromatin
was extracted and prepared using the iDeal ChIP-seq kit for Histones (Diagenode Cat#
C01010059). Tissue samples were homogenized for two minutes using the Tissue Lyser
II (Qiagen, Germany) and then fixed in 1% formaldehyde for 9 minutes (10 minutes for
adipose) to crosslink histone proteins with DNA. Chromatin was sheared using a
Bioruptor Pico (Diagenode, Cat# B01060001, Liège, Belgium) to achieve a targeted
fragment size of 200 bp. The Bioruptor water cooler was used to maintain a temperature
of 4 ◦C (10 ◦C for adipose) during shearing. Shearing occurred in cycles of 30 seconds
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where samples were rested for 30 seconds between bursts. Optimization of chromatin
extraction, ChIP, and library preparation was previously completed at Diagenode in
equine adipose, brain (parietal cortex), left ventricle (heart), lamina, liver, lung, skeletal
muscle, and ovary for part of the equine FAANG project published by Kingsley et al.
(2020). Experiments to optimize fixation and shearing times of testis were performed by
Diagenode prior to the analysis of the prioritized tissue samples. Information regarding
the homogenization, fixation, and shearing of each sample is reported in Table 1. After
crosslink reversal and DNA purification, shearing was assessed using the High
Sensitivity NGS Fragment Analysis Kit (DNF-474) on an Agilent Fragment Analyzer
(Santa Clara, CA, USA).
Immunoprecipitation (IP) of H3K27ac, H3K27me3, H3K4me1, and H3K4me3
histone marks was performed using the IP-Star Compact Automated System (Diagenode,
Cat# B03000002, Liège, Belgium) in all samples except muscle which was done
manually due to low chromatin retrieval. IP of IgG served as a negative control across
samples. Additionally, 1% of chromatin from each sample was set aside for an input
sample that serves to correct for background noise in downstream analysis. The amount
of antibody used to precipitate each histone mark and IgG differed across tissues and was
previously optimized by Diagenode (Kingsley et al., 2020) (Supplementary Table 3.1).

Library Preparation and Sequencing
Libraries for the input and four ChIP samples were prepared on the IP-Star
Compact Automated System (Diagenode, Cat# B03000002, Liège, Belgium) using the
MicroPlex Library Preparation Kit v3 (Diagenode Cat# C05010001). Seven to thirteen
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PCR cycles were used to amplify libraries and achieve appropriate concentrations for
sequencing. Libraries were double size-selected for fragments with insert sizes of ~200bp
using Agencourt® AMPure® XP (Beckman Coulter, Brea, CA, USA) and quantified
with the Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific, Q32854, Waltham,
MA, USA). Libraries were sequenced as 50bp, paired-end reads on an Illumina HiSeq
4000 platform (San Diego, CA, USA) to a target depth of 100 million raw reads for
H3K27me3 (broad mark) and 50 million raw reads for H3K327ac, H3K4me1, and
H3K4me3 (narrow marks) and input samples.

Library Mapping and Read Filtering
Adapters were removed and reads trimmed using Trim-Galore (Krueger, 2019).
Reads were mapped to EquCab3.0 with BWA-mem (Li, 2013) using the mapping script
from the slurm-genotyping pipeline (https://github.com/esrice/slurm-genotyping). PCR
duplicates were marked and removed with samtools (Li et al., 2009). Additionally, read
pairs that were unmapped, non-primary alignments, or had a mapping alignment quality
score (MAPQ) of less than 30 were removed with samtools (Li et al., 2009) to ensure that
only high-quality reads remained for peak calling. The target usable fragment count was
45 million for H3K27me3 and 20 million for the remaining marks and input samples as
outlined in the ENCODE project (https://www.encodeproject.org/chip-seq/histone/). An
H3K27ac adipose sample had less than half of the targeted usable fragments, so an
additional library was prepared and sequenced. The filtered reads from both rounds of
sequencing were merged for downstream analysis.
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Stallion Peak Calling and Tissue-Unique Peak Identification
Peaks, representing regions of read pileup, were identified using the pipeline
established by Kingsley et al. (https://faang.org/ebi/ftp.ebi.ac.uk/faang/ftp/protocols/
analyses/UCD_SOP_processing_and_analyzing_equine_PE_ChIP_data_20201230.pdf).
MACS2 (Zhang et al., 2008) was used to call peaks across all four histone marks, and
SICERpy (https://github.com/dariober/SICERpy, a wrapper for SICER from Zang et al.,
2009) was used to call peaks for H3K27me3. Paired-end (PE) reads were used for
MACS2 peak calling, while only the first reads (R1) of the stallion libraries were used for
peak calling in SICERpy (Zang et al., 2009) as this software has yet to be optimized for
PE libraries. The effective genome size, or genome fraction for SICERpy (Zang et al.,
2009), was determined by merging all input samples and determining the percentage of
the genome covered by the merged bam file. The genome size for MACS2 (Zhang et al.,
2008) was equivalent to the sum of EquCab3.0 chromosome lengths (chr1-chrX and the
mitochondrial chromosome (1660bp)). The bioinformatic parameters used in peak calling
for each mark are defined in Table 2. Overlapping peaks significant in one biological
replicate and at least called (enriched) in the other for a given mark and tissue were
determined using the output from MACS2 (Zhang et al., 2008) and bedtools intersect
(Quinlan & Hall, 2010) with default settings. Only peaks significant/enriched in both
biological replicates were considered in the study. Peaks unique to a single tissue for a
given mark were identified with bedtools (Quinlan & Hall, 2010). Microsoft Excel
(Microsoft Corporation, 2018) was used to calculate the correlations between average
usable reads and total peak number in addition to correlations between total peak number
and tissue-unique peaks.
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Data Availability
The signal tracks (bigwig) generated for each sample can be download from
https://equinegenomics.uky.edu/faangHorses_ChIP-Seq.html. Additionally, the combined
peaks and those identified for each biological replicate will be available as BED tracks
which can be found at FAANG.org under BioSampleIDs SAMEA9462146 and
SAMEA9462145.

Comparison of Peaks in Mares and Stallions
Eight of the 80 tissues in the equine FAANG biobank from two Thoroughbred
mares previously underwent ChIP-seq analysis for H3K27ac, H3K27me3, H3K4me1,
and H3K4me3 (Burns et al., 2018; Kingsley et al., 2020). The prioritized tissues included
adipose, brain parietal cortex (brain), left ventricle (heart), lamina, liver, lung, skeletal
muscle, and ovary (Kingsley et al., 2020). The ChIP-seq libraries consisted of 50bp
single-end (SE) reads generated by Diagneode’s ChIP-seq Profiling Service (Diagenode,
Cat# G02010000, Liège, Belgium; Kingsley et al., 2020). Both the raw and analyzed
datasets corresponding to the mare ChIP-seq project can be found within the FAANG
data portal under BioSample IDs SAMEA104728877 and SAMEA104728862, as well as
in the European Nucleotide Archive (ENA) under project accession PRJEB35307.
The raw fastq files from the mare ChIP-seq project were retrieved, and reads were
trimmed, mapped, and filtered as previously described. To match the SE libraries of the
mares, the first reads (R1) from the stallion libraries were processed as SE libraries and
trimmed, mapped, and filtered in the same manner as the mare libraries. The resulting
bam files for the mare and stallion ChIP and input samples were converted to bigwig files
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using deeptools bamCoverage (Ramírez et al., 2016) with default settings. The
S3V2_IDEAS_ESMP pipeline (https://github.com/guanjue/S3V2_IDEAS_ESMP) was
employed to normalize libraries for sequencing depth and background noise (Xiang et al.,
2021). The S3V2_IDEAS_ESMP pipeline uses the S3norm (Xiang et al., 2020)
normalization method to create the signal tracks used for peak calling. The signal tracks
are generated in a manner similar to MACS2 (Zhang et al., 2008), but the Poisson model
that adjusts for local background in MACS2 is replaced with a negative binomial model
to allow for flexibility in the estimates of the mean and variation within the model (Xiang
et al., 2020).
The signal tracks generated by the S3V2_IDEAS_ESMP pipeline contain 200 bp
bins with P-value scores representing the significance of the signal in each bin (Xiang et
al., 2020). The signal tracks were converted from bigwig format to bedgraph format using
UCSC’s bigWigToBedGraph package (Kent et al., 2010). Peaks were called from the
bedgraph files using MACS2 bdgpeakcall (Zhang et al., 2008) for H3K27ac, H3K4me1,
and H3K4me3 and MACS2 bdgbroadcall (Zhang et al., 2008) for H3K27me3 with a pvalue cutoff of 0.05. Peaks identified as significantly enriched in both biological
replicates of a given sex for a given mark and tissue were identified using bedtools
(Quinlan & Hall, 2010). Only the peaks identified in both of the biological replicates
within each sex were considered in the study.
Peaks unique to a tissue for a given mark and sex were identified using bedtools
(Quinlan & Hall, 2010). The overlap of peaks called for the mares and stallions were also
assessed within a given mark and tissue. Furthermore, the correlations between usable

75
reads, peak number, and unique peak number were evaluated for both the mares and
stallions using Microsoft Excel (Microsoft Corporation, 2018).

Results
Sequencing Depth and Read Filtration of Paired-End Stallion Libraries
On average, each stallion sample had 52 million (M) raw reads for H3K27ac and
H3K4me1, 55 M for H3K4me3, and 134 M raw reads for H3K27me3. Filtering removed
PCR duplicates, unmapped, and low-quality reads to create a set of reads used for peak
calling, termed usable read pairs. The average number of usable reads pairs was 28 M for
H3K27ac, 32 M for H3K4me1, 30 M for H3K4me3, and 68 M for H3K27me3. Each
stallion sample had an input sample with an average of 34 M reads used to remove
background noise during peak calling. Despite generating over 215 M raw read pairs
between the two H3K27ac_Adipose_AH3 libraries, less than 12 M usable read pairs were
available for peak calling. Additionally, the number of usable read pairs fell below the
target of 20 M usable read pairs in the other H3K27ac_Adipose replicate, in one
H3K4me3_Lamina replicate, and in the Muscle_AH3 replicates for H3K27ac, H3K4me3,
and the input sample. Six of the H3K27me3 samples fell below the 45 M usable read pair
target for this mark, yet all samples had at least 43 M usable read pairs (Supplementary
Table 3.2).

Quantifying Peaks for Paired-End Stallion Libraries
On average, each tissue had 76,668 H3K27ac peaks, 120,309 H3K4me1 peaks,
and 33,969 H3K4me3 peaks (Figure 1). Similar peak widths were observed across the
narrow marks, with average peak widths of 1,360 bp , 1,219 bp, and 1,535 bp for
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H3K27ac, H3K4me1, and H3K4me3, respectively (Table 3). The number of peaks called
for H3K27me3 varied considerably based on the software used for peak calling. MACS2
identified an average of 158,480 H3K27me3 peaks while SICERpy called an average of
32,315 H3K27me3 peaks across tissues (Figure 1). The average peak width of MACS2
H3K27me3 peaks was 1,650 bp while the average peak width of SICERpy H3K27me3
peaks was 18,466 bp (Table 3).
H3K4me3 had the lowest genome coverage across tissues with an average of
2.2% coverage. H3K27ac peaks covered an average of 4.1% of the genome across
tissues, and H3K4me1 covered approximately 6.2% of the genome in each tissue.
H3K27me3 peaks called by MACS2 covered, on average, 10.4% of the genome, while
H3K27me3 peaks called by SICERpy covered ~24.3% of the genome in each tissue
(Supplementary Table 3.3).

Tissue-Unique Peaks in Paired-End Stallion Libraries
The brain had the largest proportion of unique peaks for H34me1 and H3K27ac.
Twenty-seven percent of H3K4me1 peaks and 33% of H3K27ac peaks identified in the
brain were unique to the tissue. Nearly 50% of H3K4me3 peaks in the testis were unique.
The liver displayed the greatest proportion of unique peaks for H3K27me3 in peaks
called with both MACS2 and SICERpy. Muscle consistently demonstrated low
uniqueness across all four marks (Figure 1). The majority of peaks called for each
histone mark were shared across tissues.
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Quantifying Peaks for Single-End Stallion Reads
The first read (R1) of read pairs was used to create mock single-end sequencing in
the stallion data. The average number of usable reads for the stallion SE analysis for
H3K27ac, H3K4me1, H3K4me3, and H3K27me3 was 26 M, 30 M, 24 M, and 63 M,
respectively. Samples that fell below the 20 M usable read target included both H3K27ac
adipose samples, one H3K27ac muscle sample, one H3K4me3 muscle sample, and one
H3K4me3 lamina sample. Each of these samples had a usable read counts ranging from
11.7 M reads to 18.4 M reads. For H3K27me3, four samples fell below the 45 M usable
read target. This includes an H3K27me3 heart sample with 42 M reads, an H3K27me3
muscle sample with 41 M reads, and both H3K27me3 testis samples with 41 M reads
each (Supplementary Table 3.4)

Quantifying Peaks for Single-End Mare Reads
The number of raw reads generated from the mare samples was generally less
than that generated for the stallions. The mare samples had approximately 42 M, 49 M,
41 M, and 88 M raw reads for H3K27ac, H3K4me1, H3K4me3, and H3K27me3,
respectively. This resulted in average usable read counts of 23 M for H3K27ac, 26 M for
H3K4me1, 17 M for H3K4me3, and 26 M for H3K27me3. Four H3K27ac, two
H3K4me1, and eight H3K4me3 samples fell below their 20 M usable read target. All
mare H3K27me3 samples fell below their 45 M usable read target (Supplementary Table
3.5).
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Peaks Called from Normalized, Single-End Stallion Reads
An average of 66,586 H3K27ac, 48,605 H3K4me1, 26,273 H3K4me3, and
14,283 H3K27me3 peaks were identified across tissues in the normalized SE stallion
analysis (Figure 2). The average peak widths of the SE stallion peaks were 711 bp, 455
bp, 1,048 bp, and 2,337 bp for H3K27ac, H3K4me1, H3K4me3, and H3K27me3,
respectively (Table 3). No more than 2.6% of the genome was covered by a single
histone mark in a given tissue. The greatest genome coverage was observed for H3K27ac
with an average coverage of 1.97%. H3K4me1 peaks covered the smallest proportion of
the genome with an average coverage of 0.99% (Supplementary Table 3.6). The greatest
proportion of tissue-specific peaks were identified in the lung (21%) for H3K27me3, the
brain (43%) for H3K27ac, the liver (44%) for H3K4me1, and the testis (46%) for
H3K4me3 (Figure 2).

Peaks Called from Normalized, Single-End Mare Reads
In the mares, an average of 65,643 H3K27ac, 47,490 H3K4me1, 21,055
H3K4me3, and 6,719 H3K27me3 peaks were called across tissues (Figure 2). The
average peak width was 682 bp for H3K27ac, 442 bp for H3K4me1, 1015 for H3K4me3,
and 1,708 bp for H3K27me3 in the mares (Table 3). The H3K27ac peaks had the greatest
genome coverage for all mare samples with an average coverage of 1.86%. H3K27me3
peaks covered the smallest portion of the genome with an average of 0.48%
(Supplementary Table 3.6). In the mares, the liver had the greatest proportion of unique
peaks in H3K27ac (34%), H3K4me1 (54%), and H3K4me3 (13%). The adipose had the
greatest number of unique peaks for H3K27me3 (Figure 2).
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Direct Comparison of Mare and Stallion Regulatory Elements
Large discrepancies were observed between the number of peaks unique due to
sex for a given tissue and mark. For the broad mark, H3K27me3, the number of peaks
identified as unique in the mares never exceeded 24% for a given tissue while in the
stallion over 57% of peaks were identified as unique in all tissues. The difference in the
percent of unique peaks identified between the mares and stallions resembled the percent
difference of total peaks called between the sexes for most tissues. A similar trend was
observed across the other marks (Supplementary Table 3.7).

Correlation of Usable Reads, Peak Number, and Unique Peak Number
Positive correlations existed between the number of reads used for peak calling
and the number of peaks called across all datasets. Correlation coefficients (r) between
usable reads and total peaks called ranged from 0.17 to 0.83 across marks and datasets.
The normalization for sequencing depth in the stallion SE dataset resulted in a smaller
correlation between usable reads and peaks called for H3K27ac, HK27me3, and
H3K4me1, but not for H3K4me3. Correlations ranging between 0.20 and 0.60 remained
in the stallion SE dataset even after normalization. Furthermore, out of all three datasets
(stallion PE, stallion SE, and mare SE), the mare SE dataset that had also been
normalized for sequencing depth had the greatest correlations between usable reads and
peaks called for each mark. The number of unique peaks in a tissue was also highly
correlated with the total peaks called for that tissue. Correlations between total peaks and
unique peaks ranged from 0.52 to 0.96 across datasets and histone marks (Table 4).
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Discussion
Putative Regulatory Elements in the Stallion Called from Paired-End ChIP-seq
On average, each tissue in the stallions had over 250,000 peaks corresponding to
regulatory elements. The most common regulatory elements identified were repressors or
silencers represented by H3K27me3. This broad peak covered the greatest percentage of
the genome in the PE dataset with some tissues having repressive marks covering as
much as 32% of the genome. The enzymes that are involved in trimethylation of H3K27
often follow a positive feedback loop in which the presence of H3K27me3 increases
trimethylation of nearby histones (Oksuz et al., 2018; Schmitges et al., 2011). Although
H3K27me3 is known to create broad peaks, both the number and width of the
H3K27me3 peaks identified in the study varied considerably based on the peak calling
software. MACS2 identified nearly five times as many H3K27me3 peaks as SICER, yet
the average width of the peaks called by SICER was over ten times larger than those
called by MACS2.
Similar observations were made by Steinhauser et al. (2016) in which SICER
called considerably wider peaks than software based on MACS2 peak calling. As a gold
standard method for peak calling has yet to be established, simulated ChIP-seq datasets
are required to examine the sensitivity and specificity of peak calling software. On
simulated datasets, SICER outperformed 10 different peak-calling tools for both
identifying true peaks and limiting false positives when examining a broad-peaked
histone modification (Steinhauser et al., 2016). Since SICER was designed to better
capture broad and diffuse peaks, such as those of H3K27me3, peaks called by SICER
may better represent the proportion of the genome repressed due to H3K27me3 (Xu et al.,
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2014). MACS2 is most often used to identify narrow peaks suggesting that H3K27me3
peaks called by MACS2 may represent regions of the genome with the strongest
H3K27me3 signals. Therefore, which H3K27me3 peak set is superior will likely be
defined by the application of the dataset. For example, the greater genome coverage of
peaks called by SICERpy may be more valuable in determining which genes are inactive
or poised while the sharper H3K27me3 peaks called by MACS2 may be more helpful in
identifying primary binding sites for the polycomb complexes, PCR1 and PCR2,
involved in establishing facultative heterochromatin (Oksuz et al., 2018; Schmitges et al.,
2011). Since PCR2 deposits addition trimethylation radiating outward from an initial site
of H3K27me3, the sharper peaks may represent positions in the genome that are more
often trimethylated or potential initiator loci for facultative heterochromatin (Oksuz et al.,
2018; Schmitges et al., 2011).
The number of peaks called for each mark varied by tissue, yet muscle samples
consistently had fewer peaks across all histone marks in the stallion data. This could be
due to using a smaller amount of chromatin for library preparation; however, the same
amount of chromatin was used in the mare analysis published by Kingsely et al. (2020)
and no reduction in peak number was observed across muscle samples. The muscle
samples from one of the stallions, AH3, failed to produce the targeted number of usable
reads for H3K27ac, H3K27me3, H3K4me3, and the input sample, yet in all cases, the
number of usable reads was within 20% of the target. Even so, moderate positive
correlations between the number of reads used for peak calling and the number of peaks
called suggest that additional ChIP and/or sequencing may improve the identification of
regulatory elements in the muscle.

82
Despite the general increase in peaks called from libraries of greater sequencing
depth, it is unlikely that the additional peaks called in the more deeply sequenced
libraries were false positives. The use of input samples to normalize for background noise
and the requirement of peaks to be enriched in both biological replicates reduces the
likelihood of insignificant peaks in the final dataset. Rather, the positive correlation
between the number of usable reads and peaks called suggests that the ideal sequencing
depth has not been reached in many of the samples. Although most of the stallion
samples produced enough usable reads to achieve the thresholds established by ENCODE
(https://www.encodeproject.org/chip-seq/histone/), 20 M for narrow marks and 45 M for
broad marks, our data suggest that this threshold may not be sufficient in all tissue types.
Additional research will need to be done to determine at which point additional reads no
longer provide additional peak calls, which may differ across tissue types. Even if all
regulatory elements in the assayed tissues were not captured, those that were provide
valuable information into the genome function of those tissues.
In addition to a moderate correlation between usable reads and peaks called, a
strong positive correlation was identified between the number of peaks called in a tissue
and those identified as unique to that tissue. This correlation makes it difficult to
determine if these uniquely identified peaks represent biological differences in the
regulatory elements of tissues. Yet, in the case of the H3K27ac and H3K4me1 brain
samples, the highest percentage of uniqueness is observed in a tissue with fewer peaks
than the other samples. Many studies, including our own (see Chapter 2), have identified
a large number of transcripts that are preferentially expressed in the brain (Ramsköld et
al., 2009; Uhlén et al., 2015). Therefore, the unique H3K27ac and H3K4me1 peaks
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identified in the brain may represent some of the regulatory elements involved in
activating these differentially expressed genes. In H3K4me3, the testis had a strikingly
large proportion of promoter peaks identified as unique. Although many of these unique
peaks could be due to the larger number of total peaks called, the testis also has a great
deal of tissue specific gene expression as demonstrated by us (see Chapter 2) and others
(Ramsköld et al., 2009). Examining how the tissue-unique peaks correlate with
transcriptome data could help clarify which regulatory elements are likely to be tissuespecific and which are likely shared among tissues.

Comparing Peaks Called in Mares and Stallions from Normalized, Single-End Libraries
Previous work has identified differences in the ability to identify peaks from
single-end and paired-end sequencing (Zhang et al., 2015). Similar differences can be
observed between the total number of peaks identified in the PE stallion peaks presented
in this study and the finding published by Kingsley et al. (2020) corresponding to peaks
called from single-end sequencing. Therefore, to compare the regulatory elements
identified in mares and stallions, the stallion data was treated as single-end libraries by
only examining the first read of each read pair. As correlations were identified between
the number of reads used for peak calling and the number of peaks called, the
S3V2_IDEAS_ESMP pipeline (Xiang et al., 2021) was employed to normalize for
sequencing depth across samples in the mares and stallions. This software employs a
normalization method that generates scaling factors for each sample that are based on the
signal intensity in both enriched (peak) regions and background regions shared across
samples (Xiang et al., 2020). By adjusting the signal enrichment in both background
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regions and shared peak regions, the impact of variation in the signal-to-noise ratio, as
defined by the input sample, and the sequencing depth across samples is supposed to be
minimized. Signal tracks that represent the significance of reads enrichment across 200bp
windows is generated using a method similar to MACS2; however, the Poisson model
employed by MACS2 is replaced with a negative binomial model that allows for greater
flexibility in estimation of the mean and variances used in the model (Xiang et al., 2020).
Since the S3V2 pipeline identifies signal enrichment in a similar manner to MACS2,
MACS2 was used to call peaks for both the narrow and broad histone marks after
normalization.
Normalization of the SE libraries resulted in a smaller number of peaks being
called in the mares and stallions compared to the PE stallion data and the original data
published by Kingsley et al. (2020). Conversely, the number of unique peaks was greater
in nearly all tissues and marks in the SE normalized data than in the PE stallion data and
the original mare data. The increase in unique peaks could be attributed to the smaller
number of peaks identified across tissues and the resulting reduction in genome coverage.
Additionally, the normalization method forces peaks to fall into 200 bp windows
requiring peaks to overlap by a minimum of 200 bp to be considered shared. The original
pipeline used to assess peaks in the mares (Kingsley et al., 2020) and the stallions (PE
dataset) identifies peaks continuously across the genome and considers peaks shared if
they display any degree of overlap. Therefore, it is not surprising that the reduced
genome coverage and strict classification for overlapping peaks in the SE normalized
data sets resulted in more peaks being identified as unique across tissues.
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Although the S3V2_IDEAS_ESMP pipeline was chosen to normalize for
sequencing depth, a clear reduction in the correlation between usable reads and peaks
called was not observed. In half of the marks, the SE normalized stallion data had a
smaller correlation between reads and peaks than in the PE stallion data. Interestingly, the
highest correlations between usable reads and peaks called was observed in the mare data
normalized for sequencing depth. These finding suggests that additional library
preparation may be need in the mares’ samples, but more so, that the methods used to
correct for sequencing depth were not adequate. Due to variation in sequencing depth and
total peaks called between the mares and stallions, direct comparisons between peaks
called across sexes did not provide meaningful insight into the role of sex on the presence
of regulatory elements.
The annotation of regulatory elements has proven beneficial in characterizing the
function of the genome and associating genomic variation with disease in humans (The
ENCODE Project Consortium, 2012; Gupta et al., 2017; Warburton et al., 2016; Vinagre
et al., 2013). In this study, hundreds of thousands of putative regulatory element were
identified across tissues in the horse providing valuable information into the function of
the equine genome. The data from the previously published ChIP-seq analyses in the
mares has already aided in the identification of variants associated with distichiasis and
the characterization of centromere sliding in horses (Kingsley et al., 2020; Hisey et al.,
2020; Cappelletti et al., 2022). The ChIP-seq analyses in the stallion provide additional
support for the annotation of regulatory elements present in the tissues of adult horses.
Although peaks unique due to sex or tissue type could not be clearly defined, these
analyses demonstrate some of the shortcomings in the current methodology used for

86
identifying regulatory elements. As previously suggested, sequencing depth, sequencing
method, and peak calling software have large impacts on the outcome of ChIP-seq studies
(Steinhauser et al., 2016; Zhang et al., 2015; Xiang et al., 2020). These artifacts of data
processing impair the ability to identify biological differences across datasets. While
much progress has been made in our understanding of genome function, technological
advancements will be necessary for comparative studies into genome regulation.
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Table 3.1. Parameters for ChIP Extraction and Shearing
Adipose Brain Heart Lamina Liver
Starting Tissue
208
109
103
95
55
(mg)
Homogenization
8
5
5
5
5
Time (min)
Fixation Time
10
9
9
9
9
(min)
Shearing Volume
400
1500 1800
1800
1500
(uL)
Shearing Cycles
5x8
10
10
10
8
1
cycles
Chromatin per IP
400
700
800
900
1500
(ng)
1
Chromatin from adipose was sheared for five times for 8 cycles

Lung Muscle Testis
53
106
105
5

5

5

9

9

12

1500

1500

1300

10

10

8

1500

280

1500

Table 3.2. Software Parameters for ChIP-seq Peak Calling in MACS2 and
SICERpy
Software Parameter
Size

H3K4me1
Narrow/
Intermediate
none
0.05

H3K4me3

H3K27ac

H3K27me3

Narrow

Narrow

Broad

Size Flag
none
none
---broad
1
FDR
0.01
0.01
0.1
Genome
2,409,159,894 2,409,159,894 2,409,159,894 2,409,159,894
size
Gap Size
n/a
n/a
n/a
4
Window
n/a
n/a
n/a
200
SICERpy2
Size
Genome
n/a
n/a
n/a
0.973
Fraction
1
The FDR cutoff dictates both peak number and peak width in MACS2, so histone marks
with broader peaks have looser FDR cutoffs (https://github.com/hbctraining/Intro-toChIPseq). H3K4me1 was at one point considered to have broad peaks but has since been
determined to have an intermediate peak width (Kingsley et al., 2020).
2
SICERpy was only used to call peaks for the broad mark, H3K27me3
MACS2
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Figure 3.1. Tissue-specific peaks by histone mark. Each graph represents the peaks
detected in tissues for the corresponding marks: H3K4me1, H3K4me3, H3K27ac, and
H3K27me3. The gray area represents peaks detected in two or more tissues, while the
colored area represents peaks unique to the respective tissue. The percentages correspond
to the percent of peaks shared and unique, respectively. *Tissue did not meet targeted
usable read count
Table 3.3. Average Peak Width of Peaks Called from Paired-End and Single-End
Libraries
Average Peak Width (bp)
Analysis

H3K27ac

H3K4me1

H3K4me3

H3K27me3-M H3K27me3-S*

Stallion PE
1360
1219
1535
1650
18466
Stallion SE
711
455
1048
2337
Mare SE
682
443
1015
1708
* H3K27me3-M represents peaks called by MACS2 while H3K27me3-S represent peaks
called by SICERpy. SICERpy was only used to call peaks for the PE analysis.
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Figure 3.2. Single-End, Normalized Peaks in Tissues from Stallions and Mares
The histone mark and sex are in the title of each graph. Bar heights denote the total peaks
called for each tissue. The gray portion of the bar represent peaks shared amongst at least
two tissues for given mark and sex. The colored portion of the bar represents peaks
unique to a tissue for a given mark and sex. The percentages present within the gray
portion and within or above the colored portion of the bars denote the percentage of
peaks shared and unique, respectively.

Table 3.4 Correlations of Peak Number with Usable Reads and Unique Peak
Number
Correlation of Usable Reads1 and Total Peak Number
Analysis
Stallion PE
Stallion SE
Mare SE
Analysis
Stallion PE
Stallion SE

H3K27ac
0.62
0.49

H3K27me3
0.71
0.54

H3K4me1
0.17
0.20

H3K4me3
0.40
0.60

0.63
0.70
0.83
0.80
Correlation of Total Peak Number and Unique Peak Number
H3K27ac
0.78
0.74

H3K27me3
0.80
0.93

H3K4me1
0.52
0.81

H3K4me3
0.92
0.96

Mare SE
0.71
0.90
0.86
0.67
Usable reads were calculated as the average number reads used for peak calling across
biological replicates for a given dataset.
1

Supplementary Table 3.1. Chromatin and Antibody Amounts Used for ChIP of
Stallion Tissues
Tissue
Adipose
Brain
Heart
Lamina
Liver
Lung
Muscle
Testis

Chromatin
IP (ng)
H3K27ac
200
1
700
0.5
800
0.5
900
1
1500
2
1500
2
280
1
1500
2

Antibody Amount (µg)
H3K4me1 H3K4me3 H3K27me3
0.5
0.5
1
0.5
0.5
1
0.5
0.5
1
0.5
0.5
1
1
1
2
1
1
1
0.5
0.5
0.5
1
1
2

Tissue_Replicate

Input
H3K27me3
H3K4me3
H3K4me1
H3K27ac
Raw Read Usable Read Raw Read Usable Read Raw Read Usable Read Raw Read Usable Read Raw Read Usable Read
Pairs
Pairs
Pairs
Pairs
Pairs
Pairs
Pairs
Pairs
Pairs
Pairs
33,439,495
68,730,027 9,159,119 87,399,621 44,861,149 53,728,350 28,666,715 163,649,254 61,348,040 57,287,919
Adipose_AH3*
31,576,540
64,121,448 19,626,387 73,755,325 22,974,469 71,588,828 30,630,416 172,819,418 77,345,817 56,710,987
Adipose_AH4
30,755,494
44,153,723 28,765,325 51,902,716 39,350,197 48,165,691 30,241,426 89,113,219 51,491,049 43,318,326
Brain_AH3
29,343,590
53,550,924 37,160,660 45,941,617 33,746,787 44,199,605 31,021,321 123,828,178 70,342,831 45,370,082
Brain_AH4
31,249,453
51,902,076 32,670,198 43,860,168 31,024,746 51,509,237 33,772,055 115,749,332 46,118,523 43,193,521
Heart_AH3
41,928,341
45,090,183 28,984,929 64,302,815 36,581,050 44,069,238 32,085,936 141,578,920 65,733,036 59,163,545
Heart_AH4
32,288,689
40,535,808 23,822,100 51,986,630 23,740,973 48,277,375 24,566,917 91,980,974 58,479,470 44,456,575
Lamina_AH3
38,115,284
51,953,800 24,587,647 49,361,910 29,678,316 41,990,329 17,498,222 175,850,495 107,498,910 57,425,242
Lamina_AH4
44,077,398
55,697,969 35,488,532 45,896,092 30,855,813 69,512,707 39,270,074 126,294,140 68,466,690 66,316,277
Liver_AH3
36,917,707
46,094,286 25,054,182 40,668,291 28,444,945 58,847,906 30,313,903 192,622,865 102,590,156 51,996,032
Liver_AH4
36,330,557
51,223,693 36,116,504 54,431,763 38,103,476 45,017,929 32,393,855 120,694,401 66582349.5 50,253,855
Lung_AH3
31,782,488
38,186,321 26,003,430 46,855,312 32,873,458 48,153,388 33,420,217 174,764,785 85,469,928 44,634,249
Lung_AH4
18,251,509
59,556,353 16,214,295 50,633,437 29,979,478 71,090,388 19,682,061 80,658,715 43,452,929 43,227,165
Muscle_AH3
30,296,940
59,556,353 34,272,759 50,633,437 34,358,365 71,090,388 31,284,468 211,037,887 99,609,279 43,227,165
Muscle_AH4
36,025,563
59,238,170 42,298,232 42,281,966 29,479,553 56,479,066 27,738,020 80,574,901 44,702,585 49,793,842
Testis_AH3
36,614,620
44,952,694 31,629,947 38,900,952 27,585,434 51,773,961 34,075,725 88,305,332 45,980,036 54,636,399
Testis_AH4
Adipose_AH3_Rq* 146,616,053 2,679,759
*The "Usable Read Pairs" from both the original and resequenced (Rq) H3K27ac_Adipose_AH3 samples were merged prior to peak calling.
** The bolded cells represent samples that did not reach the usable read pair target of 45 M for H3K27me3 and 20 M for the remaining marks and input samples.

Supplementary Table 3.2. The Number of Raw Read Pairs Generated and Usable Read Pairs Remaining After Filtering for Stallion Samples
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Supplementary Table 3.3. Percentage of the Genome Covered by Stallion Peaks
Called from Paired-End (PE) Sequencing Reads

Tissue
Adipose
Brain
Heart
Lamina
Liver
Lung
Muscle
Testis
Average

Genome Coverage (%) of Stallion PE Peaks
H3K27ac H3K4me1 H3K4me3 H3K27me3- M
3.5
8.4
2.8
13.9
4.2
5.3
1.9
4.5
4.9
7.6
2.0
12.0
4.1
5.7
1.6
11.3
4.9
8.8
2.1
17.4
4.4
7.9
2.0
11.2
3.5
3.8
1.7
5.2
3.4
2.3
3.3
7.9
4.1

6.2

2.2

10.4

H3K27me3-S
27.0
20.4
26.2
24.0
31.9
24.4
21.9
18.8
24.3

*H3K27me3-M refers to peaks called by MACS2 and H3K27me3-S corresponds to
peaks called by SICER

Supplementary Table 3.4. The Number of Raw Reads (SE) Generated and Usable
Read Remaining After Filtering for Stallion SE Libraries
Usable Reads
Tissue_Replicate
H3K27ac
H3K4me1
H3K4me3
H3K27me3
Input
Adipose_AH3
11,726,267
42,727,844 26,161,927
57,544,729 31,599,110
Adipose_AH4
18,440,913
22,068,341 26,765,709
71,542,011 29,887,369
Brain_AH3
26,978,372
37,408,812 25,181,921
47,348,607 28,706,086
Brain_AH4
34,781,010
32,090,313 26,573,113
65,584,580 27,875,383
Heart_AH3
29,990,876
29,788,367 26,198,176
42,563,147 29,521,680
Heart_AH4
26,751,589
34,778,776 25,018,901
60,914,733 39,119,625
Lamina_AH3
22,446,342
22,657,405 21,539,456
54,036,862 30,634,716
Lamina_AH4
22,885,088
28,326,171 14,646,913
98,780,005 35,767,290
Liver_AH3
32,957,464
29,199,086 29,167,280
62,980,452 41,238,530
Liver_AH4
23,030,281
27,017,793 22,634,290
94,798,294 34,684,694
Lung_AH3
33,349,291
36,151,847 25,697,164
61,807,452 33,935,456
Lung_AH4
24,427,976
31,255,694 25,972,450
79,021,225 29,726,014
Muscle_AH3
15,369,015
28,618,869 16,387,282
40,970,497 17,174,306
Muscle_AH4
31,519,488
32,612,832 25,991,828
92,652,752 28,486,147
Testis_AH3
39,807,561
28,008,508 24,624,383
41,072,942 33,884,571
Testis_AH4
29,894,317
26,283,274 29,574,827
41,757,310 34,345,132
* The bolded cells represent samples that did not reach the usable read pair target of 45 M for
H3K27me3 and 20 M for the remaining marks and input samples.

* The bolded cells represent samples that did not reach the usable read pair target of 45 M for H3K27me3 and 20 M for the remaining marks and input samples.

Supplementary Table 3.5. The Number of Raw Reads (SE) Generated and Usable Reads Remaining After Filtering for Mare Samples
Input
H3K27me3
H3K4me3
H3K4me1
H3K27ac
Tissue_Replicate
Raw Reads Usable Reads Raw Reads Usable Reads Raw Reads Usable Reads Raw Reads Usable Reads Raw Reads Usable Reads
26,283,444
39,467,535 43,121,326
22,382,348 78,893,855
22,976,419 46,573,713
20,285,907 42,474,777
42,824,865
Adipose_AH1
29,981,696
34,455,960 47,030,891
20,835,785 67,639,834
25,503,801 44,139,072
29,598,127 42,239,655
48,915,696
Adipose_AH2
26,563,224
26,689,432 43,523,581
10,785,248 58,814,934
24,123,648 40,856,531
21,565,725 39,837,681
43,974,930
Brain_AH1
27,285,703
27,707,092 46,263,586
14,697,550 75,947,873
13,786,304 34,937,537
20,720,820 36,538,575
40,688,277
Brain_AH2
25,385,371
14,039,244 44,242,333
11,695,832 65,993,929
31,223,234 41,465,195
18,483,810 95,807,379
36,136,771
Heart_AH1
25,061,680
23,580,422 41,709,767
14,340,384 78,002,179
28,549,374 41,419,274
15,570,052 44,745,372
35,569,728
Heart_AH2
26,395,838
19,967,360 43,576,023
20,524,291 59,375,211
21,314,248 41,437,394
22,518,048 42,526,642
37,994,974
Lamina_AH1
21,390,454
23,166,407 33,994,964
20,649,024 64,949,083
24,127,700 45,700,886
19,272,229 44,412,262
35,912,806
Lamina_AH2
26,116,877
24,509,202 44,555,911
14,528,367 72,283,887
33,542,235 41,146,455
27,972,377 73,403,419
44,216,613
Liver_AH1
28,414,218
30,853,685 52,257,642
14,805,249 73,937,379
34,116,013 39,119,796
23,236,188 52,222,345
38,117,020
Liver_AH2
26,906,108
24,920,879 44,375,386
22,092,067 57,340,656
40,515,514 44,451,765
31,436,935 70,386,807
54,431,033
Lung_AH1
29,106,329
30,077,163 48,412,181
22,196,353 61,251,734
36,479,723 42,712,275
25,395,989 57,250,724
57,372,074
Lung_AH2
23,118,540
28,738,934 40,839,362
19,009,675 82,238,330
19,018,397 40,544,487
19,826,000 37,596,912
44,360,817
Muscle_AH1
26,760,212
28,617,004 41,413,933
7,056,497 71,172,395
20,469,885 35,257,194
24,938,732 32,919,675
46,011,699
Muscle_AH2
24,444,447
26,430,617 38,701,828
21,501,928 67,738,747
26,186,014 40,900,341
21,954,835 41,748,385
35,313,302
Ovary_AH1
26,508,982
23,487,440 41,753,846
20,413,333 57,017,668
22,695,425 36,698,698
26,035,899 35,814,629
39,121,462
Ovary_AH2
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Supplementary Table 3.6. Percentage of the Genome Covered by Single-End,
Normalized Peaks in Stallions and Mares
Genome Coverage (%) of Stallion SE Peaks
Tissues
Adipose
Brain
Heart
Lamina
Liver
Lung
Muscle
Testis
Average

H3K27ac
1.24
2.31
2.55
2.12
2.22
2.01
1.63
1.70
1.97

H3K4me1
1.22
0.58
1.17
0.81
1.83
1.57
0.56
0.17
0.99

H3K4me3
1.24
1.03
1.13
0.97
1.19
1.15
0.97
1.43
1.14

H3K27me3-M
1.55
0.78
1.29
1.62
1.35
1.90
1.40
1.21
1.39

Genome Coverage (%) of Mare SE Peaks
Tissues
H3K27ac
H3K4me1
Adipose
2.01
0.85
Brain
1.84
0.16
Heart
1.71
1.42
Lamina
1.60
0.92
Liver
2.13
1.70
Lung
1.94
1.17
Muscle
1.84
0.44
Ovary
1.79
0.80
Average
1.86
0.93
* All peaks were called with MACS2

H3K4me3
0.99
0.87
0.76
0.92
0.84
0.98
0.75
0.99
0.89

H3K27me3-M
0.68
0.46
0.26
0.34
0.46
0.50
0.57
0.57
0.48
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Supplementary Table 3.7. Peaks Unique to Mares and Stallions within Tissues and
Differences in the Percentage of Unique Peaks and Total Peaks Between Sexes
H3K27me3
Tissue

Sex

Ovary
Testis

Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion

Tissue

Sex

Adipose
Brain
Heart
Lamina
Liver
Lung
Muscle

Adipose
Brain
Heart
Lamina
Liver
Lung
Muscle
Ovary
Testis

Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion

Combined
Peaks
8,019
15,172
5,195
8,127
4,892
12,997
5,962
16,539
7,254
14,638
6,758
19,818
8,429
14,041
7,245
12,932
Combined
Peaks
69,314
46,994
63,270
61,631
58,909
81,127
65,521
74,724
76,104
73,938
66,259
70,646
63,693
59,008
62,078
64,616

% Unique
11.5
64.6
23.5
57.8
6.5
75.8
6.1
78.2
8.1
66.5
4.4
76.1
13.2
61.2
21.8
63.4
H3K27ac
% Unique
58.4
26.8
40.0
50.3
19.6
52.2
28.6
46.4
36.3
38.0
38.4
42.4
42.6
33.3
52.8
50.2

Difference in
Percent Unique

Difference in
Total Peak (%)

53.1

47.1

34.3

36.1

69.3

62.3

72.2

64.0

58.4

50.4

71.8

65.9

48.0

40.0

41.6

44.0

Difference in
Percent Unique

Difference in
Total Peak (%)

31.7

32.2

10.3

2.6

32.5

27.3

17.8

12.3

1.6

2.8

4.0

6.2

9.4

7.4

2.6

3.9
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H3K4me1
Tissue
Adipose
Brain
Heart
Lamina
Liver
Lung
Muscle
Ovary
Testis

Sex
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion
Mare
Stallion

Combined
Peaks
45,184
57,244
14,417
33,856
61,475
56,432
46,763
47,219
77,898
75,012
58,595
70,620
29,602
33,876
45,988
14,583

% Unique
38.1
57.3
50.7
82.9
47.2
35.8
49.1
44.6
36.2
37.7
32.8
49.8
50.5
59.8
87.6
55.1
H3K4me3

Difference in
Percent Unique

Difference in
Total Peak (%)

19.2

21.1

32.2

57.4

11.4

8.2

4.5

1.0

1.5

3.7

17.1

17.0

9.3

12.6

32.5

68.3

Combined
Difference in
Difference in
% Unique
Peaks
Percent Unique Total Peak (%)
Mare
20,925
9.5
Adipose
27.3
29.3
Stallion
29,614
36.8
Mare
20,545
12.4
Brain
13.1
12.2
Stallion
23,399
25.5
Mare
19,114
2.7
Heart
31.2
24.1
Stallion
25,174
33.9
Mare
22,677
14.5
Lamina
1.4
0.0
Stallion
21,902
15.9
Mare
20,255
4.3
Liver
30.6
21.4
Stallion
25,771
34.9
Mare
21,958
9.9
Lung
15.8
12.7
Stallion
25,149
25.7
Mare
20,427
7.8
Muscle
18.7
7.0
Stallion
21,964
26.5
Ovary
Mare
22,540
21.0
33.7
41.2
Testis
Stallion
38,810
54.7
* Difference in Total Peak (%) was calculated as the difference in combined peaks
divided by the larger of the two combined peak numbers.
Tissue

Sex
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CHAPTER 4: WHOLE-GENOME SEQUENCING TO INVESTIGATE A POSSIBLE
GENETIC BASIS OF PEROSOMUS ELUMBIS IN A CALF RESULTING FROM A
CONSANGUINEOUS MATING

Barber, A., Helms, A., Thompson, R., Whitlock, B., Steffen, D., & Petersen, J. (2021) Wholegenome sequencing to investigate a possible genetic basis of perosomus elumbis in a calf
resulting from a consanguineous mating. Translational Animal Science, 5(Supplement_S1), S1–
S5.

Introduction
Perosomus elumbis (PE) is a lethal, congenital defect marked by aplasia of the
lumbar and sacral spine and spinal cord. Contracture of the hind limbs is also commonly
observed in affected individuals. PE has been reported in many domestic species, with
numerous case reports in Holstein cattle in the past two decades (Jones, 1999; Karakaya
et al., 2013; Agerholm et al., 2014) The etiology of PE remains unknown. In one instance
a stillborn Holstein calf with PE was found to be infected with Bovine Viral Diarrhea
Virus (BVDV) (Karakaya et al., 2013), and thus it is possible PE may be due to genetic
and/or environmental factors. Recently, a stillborn Angus calf was diagnosed with PE
following an accidental mother-son mating (Helms et al., 2020). BVDV was not detected
in the affected Angus calf, dam, nor sire. Due to the relationship between the sire and
dam it was hypothesized that a novel, recessive genetic variant may be responsible for the
development of PE in this Angus calf. The objective of this study was to use wholegenome sequencing to address this hypothesis and identify candidate variants for PE in
this calf.
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Materials and Methods
IACUC Statement
All procedures and protocols were performed following the University of
Nebraska-Lincoln’s Institutional Animal Care and Use Committee guidelines.

Sample Collection and DNA Isolation
Case presentation and diagnosis are reported in Helms et al. (2020). Tissue
samples were collected from the affected calf following necropsy at the University of
Tennessee Veterinary Medical Center. Blood samples were also taken from the dam, sire,
and ten paternal half-siblings; tissue and blood were sent to the University of NebraskaLincoln. DNA was isolated from tissue and blood utilizing Qiagen Gentra Puregene Kits
(Gentra Systems, Minneapolis, MN). Paternity was verified for all calves using the
commercially available SeekSire parentage assay at Neogen GeneSeek (Lincoln, NE).

Whole Genome Sequencing and Variant Filtering
DNA collected from the affected calf, the dam, the sire, and three paternal halfsiblings was sent to Admera Health (South Plainfield, NJ) for KAPA library prep and
150bp paired-end sequencing on an Illumina NovaSeq to a targeted sequencing depth of
12X. After trimming adapter sequences and poor quality bases (TrimGalore; Wu et al.,
2011) sequence reads from the calf, dam, sire, and half siblings along with 27 other
Angus and Angus-cross animals were mapped to the UOA_Angus_1 reference genome
with BWA-MEM (Li, 2013).
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Variants were called using Freebayes (Garrison and Marth, 2012) and annotated
using SnpEff (Cingolani et al., 2012). SnpSift was also used to filter variants in which the
affected calf was homozygous and both the dam and sire were heterozygous. With the
assumption that PE is rare in Angus cattle, variants were further pruned using VCFtools
(Danecek et al., 2011) to select only variants in which the alternative allele count was
between four and seven to account for a homozygous calf, two heterozygous parents, and
allow for the half-siblings to be heterozygous. Variants were further reduced to include
only those predicted to have a moderate to high impact. Variants fitting the criteria were
further investigated. Variants were remapped to the ARS-UCD1.2 reference genome
using NCBI’s Remap tool to determine if the variants had been previously reported.

PCR and Sanger Sequencing
Primers for regions of interest were developed using sequence from the
UOA_Angus_1 reference genome. Oligonucleotides were designed using IDT’s
PrimerQuest Tool. PCR products were amplified using an annealing temperature ranging
between 54-58 C and visualized on 1.2% agarose gels. PCR products were sent to ACGT
Inc. (Wheeling, IL) for Sanger sequencing. Sequence results were visualized using Gene
Code Corporation’s Sequencher.

Sequence Read Archive Search
A search of NCBI’s Sequence Read Archive (SRA) was conducted using a variant
Search pipeline (https://github.com/SichongP/SRA_variant_search); NCBI’s Remap
function was used to identify coordinates across genome assemblies. The frameshift
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variant was not assessed in the SRA search due to difficulty interpreting indels using this
method.

Results
Candidate Variant Filtering
Variant calling across the 31 Angus and Angus cross individuals, including the
affected calf, the dam, the sire, and three half siblings, identified 21,223,927 variants
across the genome. Using SnpSift to filter for variants in which the calf was homozygous
for the variant and the dam and sire were heterozygous yielded 506,813 variants.
Removing variants at high frequency in the data set reduced candidate variants to 14,011.
Filtering by predicted impact as annotated in SnpEff resulted in 77 variants with a
predicted moderate impact and 5 with predicted high impact. Predicted high impact
variants were excluded from further analysis if they were previously annotated and a
carrier was found in the original 39 screened animals or if the variant was found in the
homozygous state in any individual(s) other than the affected calf. After removing
variants fitting those criteria, the final candidate variant list consisted of 18 missense
variants and one frameshift resulting from a one base pair deletion. Three of the 19
candidate variants were not previously annotated on Ensembl (Table 4.1). The frameshift
variant was in exon 4 of protein tyrosine kinase 7 (PTK7) and is predicted to result in a
premature stop codon prior to the end exon. Due to its putative deleterious impact on
gene function, this variant was further studied as a candidate causal variant.
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Sanger Sequencing Verification of Frameshift Mutation in PTK7 and SRA results
Sanger sequencing confirmed the presence of a homozygous, one base pair
deletion in the affected calf. Additionally, six of 10 half-siblings were heterozygous for
the deletion (Figure 4.1).
The search of the Sequence Read Archive (SRA) resulted in genotypes of 883
additional cattle including 96 Angus and Angus cross. Through this analysis, individuals
homozygous for variants were identified at 15 of the 18 missense loci; the indel in PTK7
was not able to be queried.
The three remaining missense variants in KDM1A, C2H2orf66, and ZSCAN26,
and one frameshift variant in PTK7 remained as candidate causal variants (Table 4.1).
From the SRA data, 1 Holstein was heterozygous for the KDM1A variant; 2 Tyrolean
Grey cattle, 1 Chianina, and 1 Romagnola were heterozygous for the C2H2orf66 variant;
and 2 Angus, 1 Chi-Angus cross, and 1 Holstein were heterozygous for the ZSCAN26
variant.

Discussion
In this study, missense mutations in KDM1A, C2H2orf66, and ZSCAN26, as well
as a frameshift mutation in PTK7 could not be ruled out as causative of PE in this Angus
calf. PE is a lethal congenital defect that results in aplasia of the lumbar spine and
frequent contracture of the hind limbs. Although relatively rare in Angus cattle, numerous
cases of PE have been reported in Holstein cattle. The cause of PE has yet to be
determined with both environment and genetics suspected to play a role. In this case, the
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affected Angus calf was the result of a consanguineous mating suggesting that a recessive
mutation may be the cause.
Of the four variants remaining after filtering out those that did not fit the
hypothesized mode of inheritance, and those at high frequency in other cattle, the
missense mutation in KDM1A and the frameshift mutation in PTK7 are strong functional
candidates due to their roles in early development. KDM1A is involved in epigenetic
regulation of embryonic gene expression (Ancelin et al., 2016), while PTK7 functions in
the planar cell polarity (PCP) pathway that regulates cell movement and migration
(Berger et al., 2017).
KDM1A is an histone 3 lysine 4 (H3K4) lysine demethylase that functions to remove
enhancer marks from histones. These epigenetic marks influence early development in
part by regulating the spaciotemporal activation of genes which orchestrates proper
embryonic development (Ancelin et al., 2016). Dysregulation of KDM1A can result in
developmental arrest and altered patterns of gene expression in the developing embryos
(Ancelin et al., 2016).
PTK7, a member of the tyrosine kinase family, plays a role in the planar cell polarity
(PCP) pathway. This pathway establishes polarity in cells and regulates cell movement
and migration in embryonic development (Berger et al., 2017). This gene is of particular
interest as it has been implicated in congenital scoliosis in zebrafish (Hayes et al., 2014)
demonstrating a clear role in the development of the fetal spine. Additionally, another
gene with a paralog in this pathway, VANLG1, has been implicated in an analogous
human disorder called caudal regression syndrome (CRS) (Kibar et al., 2007; Porsch et
al., 2016). Furthermore, VANGL2, which directly interacts with PTK7 in the PCP
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pathway has also been implicated in neural tube defects (Kibar et al, 2011). These studies
demonstrate a clear role of PTK7 and the PCP pathway in spinal development making a
frameshift mutation in PTK7 a strong functional candidate for PE in cattle.
Although PTK7 provides a strong functional candidate for PE, this study is limited
due to the availability of a single affected calf. This study should be supplemented with
additional affected calves as cases are reported. Furthermore, as new sequence reads
become available in the SRA database, additional animals can be screened for the
associated variants found in this study. Due to the rarity of this condition, this study could
be extended to consider affected calves from other breeds.

Implications
The accumulation of lethal recessive variation within breeds negatively impacts
production and breed health. With the growing use of artificial insemination (AI), prolific
carrier bulls can rapidly increase the allele frequency of recessive disorders within the
breed. Using whole-genome sequencing, disease-associated and disease-causing variation
can be identified. Although a causative variant was not validated in this study, in the case
that would occur, genetic testing could allow for informed matings to eliminate the
production of affected individuals.
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Table 4.1. Candidate variants for perosomus elumbis. Italicized rows indicate that no
individuals were homozygous for the variant in the Sequence Reads Archive (SRA)
search. Bolded rows indicate variants with a predicted high impact on gene function from
SnpEff (Cingolani et al., 2012). Positions labelled UOAcorrespon d to the
UOA_Angus_1 reference genome, and positions labelled ARS correspond to the
ARS_UCD1.2 reference genome. Previously annotated variants are noted under Variant
ID. Type represents the predicted position/outcome observed in the UOA_Angus_1
reference genome (top) and the ARS_UCD1.2 reference genome (bottom).
Chr

2

2

4

15

15

17

17

Position
UOA:
6567555
ARS:
129835952
UOA:
50768895
ARS:
85400473
UOA:
6313462
ARS:
113625394
UOA:
63709344
ARS:
63626227
UOA:
63709425
ARS:
63626308
UOA:
51162578
ARS:
51449160
UOA:
51555593
ARS:
51850428

Gene

Reference

Variant

KDM1A

C

T

C2H2orf66

ASIC3

QSER1

QSER1

NCOR2

DNAH10

T

C

A

CA

C

T

Type

Variant
ID

Missense

Novel

Missense

Novel

Missense

-

Intergenic

rs71994
4515

Missense

-

Missense

rs46645
5595

Missense

-

Intronic

rs38072
3979

Missense

-

Intronic

rs79940
5617

Missense

-

Missense

rs47293
1263

Missense

-

Missense

rs13608
8999

C

T

G

GG

T

C
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22

23

23

23

23

23

23

23

23

28

28

28

UOA:
59081586
ARS:
58980413
UOA:
22015758
ARS:
30587728
UOA:
22140420
ARS:
30463098
UOA:
22181166
ARS:
30422277
UOA:
22192722
ARS:
30410722
UOA:
22192789
ARS:
30410655
UOA:
23246829
ARS:
29295898
UOA:
23452894
ARS:
29099147
UOA:
35361113
ARS:
16744942
UOA:
25626059
ARS:
25846885
UOA:
26696544
ARS:
26918561
UOA:
30658181
ARS:
30876012

EFCC1

ZNF165

ZSCAN9

ZSCAN26

PGBD1

PGBD1

OR1O9

OR2H1D

PTK7

TSPAN15

ADAMTS1
4

DUSP13

G

G

C

C

G

C

C

A

CG

A

C

C

Missense

Novel

Missense

Novel

Missense

-

Missense

rs52664
9482

Missense

-

Downstream

rs46383
5998

Missense

-

Missense

rs52198
6257

Missense

-

Missense

rs43213
9616

Missense

-

Missense

rs44983
2006

Missense

-

CNV

nsv835
503

Missense

-

Downstream/CNV

rs80018
1923

Frameshift

Novel

Frameshift

Novel

Missense

-

Missense

rs46936
9204

Missense

-

Missense

rs13538
1293

Missense

-

Missense

rs37959
4626

T

A

T

A

A

T

T

C

G

G

T

T
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A)

B)

Individual
Affected Calf
Dam
Sire
Half Sibling 1
Half Sibling 2
Half Sibling 3
Half Sibling 4
Half Sibling 5
Half Sibling 6
Half Sibling 7
Half Sibling 8
Half Sibling 9
Half Sibling 10

Genotype
-/C/C/C/C/C
C/C/C/C/C/C
C/C
C/C
C/-

Figure 4.1. Sanger sequencing confirms the presence of a one base pair deletion in
PTK7. A) Sequence data of exon 4 of PTK7 from the affected calf, the dam, and two half
siblings depicts the presence of a deletion for which the affected calf was homozygous,
the dam and half-sibling heterozygous, and second half-sibling wildtype. B) Genotypes
of the affected calf, the dam, the sire, and ten half-siblings at the candidate locus in
PTK7. A dash (-) indicates the 1bp deletion.
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